<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="mbt213825" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jats-oasis2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microb Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">Microb Biotechnol</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1751-7915</journal-id><journal-id journal-id-type="publisher-id">MBT2</journal-id><journal-title-group><journal-title>Microbial Biotechnology</journal-title></journal-title-group><issn pub-type="epub">1751-7915</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8867987</article-id><article-id pub-id-type="pmid">34310825</article-id><article-id pub-id-type="doi">10.1111/1751-7915.13825</article-id><article-id pub-id-type="publisher-id">MBT213825</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>Enhancement of edeine production in <italic toggle="no">Brevibacillus brevis</italic> X23 via <italic toggle="no">in&#x000a0;situ</italic> promoter engineering</article-title><alt-title alt-title-type="right-running-head">
<italic toggle="yes">In situ</italic> enhancement of edeine production</alt-title><alt-title alt-title-type="left-running-head">
<italic toggle="yes">Q. Liu</italic> et&#x000a0;al.</alt-title></title-group><contrib-group><contrib id="mbt213825-cr-0001" contrib-type="author"><name><surname>Liu</surname><given-names>Qingshu</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0655-5651</contrib-id><xref rid="mbt213825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mbt213825-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="mbt213825-note-0001" ref-type="author-notes">
<sup>
<sup>&#x02020;</sup>
</sup>
</xref></contrib><contrib id="mbt213825-cr-0002" contrib-type="author"><name><surname>Zhang</surname><given-names>Liang</given-names></name><xref rid="mbt213825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mbt213825-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="mbt213825-note-0001" ref-type="author-notes">
<sup>
<sup>&#x02020;</sup>
</sup>
</xref></contrib><contrib id="mbt213825-cr-0003" contrib-type="author"><name><surname>Wang</surname><given-names>Yunsheng</given-names></name><xref rid="mbt213825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt213825-cr-0004" contrib-type="author"><name><surname>Zhang</surname><given-names>Cuiyang</given-names></name><xref rid="mbt213825-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mbt213825-cr-0005" contrib-type="author"><name><surname>Liu</surname><given-names>Tianbo</given-names></name><xref rid="mbt213825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt213825-cr-0006" contrib-type="author"><name><surname>Duan</surname><given-names>Caichen</given-names></name><xref rid="mbt213825-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mbt213825-cr-0007" contrib-type="author"><name><surname>Bian</surname><given-names>Xiaoying</given-names></name><xref rid="mbt213825-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="mbt213825-cr-0008" contrib-type="author"><name><surname>Guo</surname><given-names>Zhaohui</given-names></name><xref rid="mbt213825-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mbt213825-cr-0009" contrib-type="author"><name><surname>Long</surname><given-names>Qingshan</given-names></name><xref rid="mbt213825-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mbt213825-cr-0010" contrib-type="author"><name><surname>Tang</surname><given-names>Ying</given-names></name><xref rid="mbt213825-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mbt213825-cr-0011" contrib-type="author"><name><surname>Du</surname><given-names>Jie</given-names></name><xref rid="mbt213825-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="mbt213825-cr-0012" contrib-type="author"><name><surname>Liu</surname><given-names>Aiyu</given-names></name><xref rid="mbt213825-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="mbt213825-cr-0013" contrib-type="author"><name><surname>Dai</surname><given-names>Liangying</given-names></name><xref rid="mbt213825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="mbt213825-cr-0014" contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Dingjun</given-names></name><xref rid="mbt213825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="mbt213825-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><address><email>dingjun64@126.com</email></address></contrib><contrib id="mbt213825-cr-0015" contrib-type="author" corresp="yes"><name><surname>Chen</surname><given-names>Wu</given-names></name><xref rid="mbt213825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>chenwuwarrior@163.com</email></address></contrib></contrib-group><aff id="mbt213825-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">College of Plant Protection</named-content>
<institution>Hunan Agricultural University</institution>
<city>Changsha</city>
<postal-code>410128</postal-code>
<country country="CN">China</country>
</aff><aff id="mbt213825-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Hunan Province Engineering Research Center for Agricultural Microbiology Application</named-content>
<institution>Hunan Institute of Microbiology</institution>
<city>Changsha</city>
<postal-code>410009</postal-code>
<country country="CN">China</country>
</aff><aff id="mbt213825-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">College of Agronomy</named-content>
<institution>Hunan Agricultural University</institution>
<city>Changsha</city>
<postal-code>410128</postal-code>
<country country="CN">China</country>
</aff><aff id="mbt213825-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Helmholtz International Lab for Anti&#x02010;Infectives, Shandong University&#x02010;Helmholtz Institute of Biotechnology, State Key Laboratory of Microbial Technology</named-content>
<institution>Shandong University</institution>
<city>Qingdao</city>
<postal-code>266237</postal-code>
<country country="CN">China</country>
</aff><aff id="mbt213825-aff-0005">
<label>
<sup>5</sup>
</label>
<institution>Hunan University of Technology and Business</institution>
<city>Changsha</city>
<postal-code>410205</postal-code>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
For correspondence: *E&#x02010;mail <email>dingjun64@126.com</email>; Tel. +86&#x02010;731&#x02010;8886&#x02010;5515; Fax +86&#x02010;731&#x02010;8886&#x02010;5515. **Email <email>chenwuwarrior@163.com</email>; Tel. +86&#x02010;731&#x02010;8461&#x02010;8163; Fax +86&#x02010;731&#x02010;8461&#x02010;8163.<break/>
</corresp><fn fn-type="equal" id="mbt213825-note-0001"><label>
<sup>&#x02020;</sup>
</label><p>These two authors contributed equally to this paper.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>7</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2022</year></pub-date><volume>15</volume><issue seq="170">2</issue><issue-id pub-id-type="doi">10.1111/mbt2.v15.2</issue-id><issue-title>Thematic Issue: New advancements in antimicrobial research</issue-title><fpage>577</fpage><lpage>589</lpage><history>
<date date-type="rev-recd"><day>22</day><month>4</month><year>2021</year></date>
<date date-type="received"><day>20</day><month>1</month><year>2021</year></date>
<date date-type="accepted"><day>26</day><month>4</month><year>2021</year></date>
</history><permissions><!--&#x000a9; 2022 John Wiley & Sons Ltd and Society for Applied Microbiology--><copyright-statement content-type="article-copyright">&#x000a9; 2021 The Authors. <italic toggle="yes">Microbial Biotechnology</italic> published by Society for Applied Microbiology and John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:MBT2-15-577.pdf"/><abstract id="mbt213825-abs-0001"><title>Summary</title><p>Edeines, a group of cationic antimicrobial peptides produced by the soil bacterium Brevibacillus, have broad biological effects, such as antimicrobial, anticancer and immunosuppressive activities. However, the yield of edeines in wild&#x02010;type (WT) <italic toggle="yes">Brevibacillus</italic> is extremely low, and chemical synthesis of edeines is a time&#x02010;consuming process. Genetic engineering has proven to be an effective approach to produce antibiotics with high yield. In this study, the <underline underline-style="single">ede</underline>ine <underline underline-style="single">b</underline>iosynthetic <underline underline-style="single">g</underline>ene <underline underline-style="single">c</underline>luster (<italic toggle="yes">ede</italic> BGC), which is involved in edeine production, was identified and characterized in <italic toggle="yes">Brevibacillus brevis</italic> X23. To improve edeine production in <italic toggle="yes">B. brevis</italic> X23, the <italic toggle="yes">ede</italic> BGC promoter was replaced with six different promoters, P<sub>mwp</sub>, P<sub>spc</sub>, P<sub>xylA</sub>, P<sub>shuttle&#x02010;09</sub>, P<sub>grac</sub> or P<sub>43</sub>, through double&#x02010;crossover homologous recombination. The new promoters significantly increased the expression of the <italic toggle="yes">ede</italic> BGC as well as edeine production by 2.9&#x02009;&#x000b1;&#x02009;0.4 to 20.5&#x02009;&#x000b1;&#x02009;1.2&#x02010;fold and 3.6&#x02009;&#x000b1;&#x02009;0.1to 8.7&#x02009;&#x000b1;&#x02009;0.7&#x02010;fold respectively. The highest yield of edeines (83.6&#x02009;mg&#x02009;l<sup>&#x02212;1</sup>) was obtained in <italic toggle="yes">B. brevis</italic> X23 with the P<sub>mwp</sub> promoter. This study provides a practical approach for producing high yields of edeines in <italic toggle="yes">B</italic>. <italic toggle="yes">brevis</italic>.</p></abstract><abstract abstract-type="graphical" id="mbt213825-abs-0002"><p>The new promoters significantly increased expression of the ede BGC as well as edeine production by 2.9&#x02009;&#x000b1;&#x02009;0.4 to 20.5&#x02009;&#x000b1;&#x02009;1.2&#x02010;fold and 3.6&#x02009;&#x000b1;&#x02009;0.1to 8.7&#x02009;&#x000b1;&#x02009;0.7&#x02010;fold, respectively. The highest yield of edeines (83.6&#x02009;mg&#x02009;l<sup>&#x02212;1</sup>) was obtained in B. brevis X23 with the Pmwp promoter. This study provides a practical approach for producing high yields of edeines in B. brevis.<boxed-text position="anchor" content-type="graphic" id="mbt213825-blkfxd-0001"><graphic xlink:href="MBT2-15-577-g003.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><funding-group><award-group id="funding-0001"><funding-source>Key Research and Development Project in Changsha</funding-source><award-id>kq2004031</award-id></award-group><award-group id="funding-0002"><funding-source>National Natural Science Foundation of Hunan Province</funding-source><award-id>2019JJ40119</award-id><award-id>2019JJ40153</award-id><award-id>2019JJ40169</award-id></award-group><award-group id="funding-0003"><funding-source>Special Project for Construction of Innovative Province in Hunan</funding-source><award-id>2019NK2192</award-id><award-id>2020NK2006</award-id></award-group><award-group id="funding-0004"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>31772216</award-id><award-id>32000047</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="0"/><page-count count="589"/><word-count count="7789"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2022</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.1 mode:remove_FC converted:24.02.2022</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="mbt213825-cit-1001">
<source>Microb. Biotechnol.</source> (<year>2022</year>) <volume>15</volume>(<issue>2</issue>), <fpage>577</fpage>&#x02013;<lpage>589</lpage>
</mixed-citation>
</p></notes></front><body id="mbt213825-body-0001"><sec id="mbt213825-sec-0001"><title>Introduction</title><p>Edeines are a group of linear pentapeptides produced by the soil bacterium Brevibacillus (Westman <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0037" ref-type="bibr">2013</xref>). Edeines A, B, D and F, which exhibit remarkable antibiotic activities, exist as two isomers, the active isomer <italic toggle="yes">&#x003b1;</italic> and the inactive isomer <italic toggle="yes">&#x003b2;</italic> (Fig.&#x02009;<xref rid="mbt213825-fig-0001" ref-type="fig">1</xref>). Among them, edeines A<sub>1</sub> and B<sub>1</sub> have broad inhibitory activity against Gram&#x02010;positive and Gram&#x02010;negative bacteria, fungi, mycoplasmas and cancer cells (Hill <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0011" ref-type="bibr">1994</xref>; Czajgucki <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0004" ref-type="bibr">2006</xref>; Johnson <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0013" ref-type="bibr">2020</xref>) as well as substantial immunosuppressive activity in mice (Kiero&#x00144;ska <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0016" ref-type="bibr">1976</xref>). Edeines inhibit DNA synthesis at low concentrations (&#x02264;&#x02009;15&#x02009;&#x003bc;g&#x02009;ml<sup>&#x02212;1</sup>) and suppress protein synthesis at high concentrations (&#x02265;&#x02009;150&#x02009;&#x003bc;g&#x02009;ml<sup>&#x02212;1</sup>) through binding to the P&#x02010;site of the 30S ribosomal subunit to block t&#x02010;RNA binding, contributing to their antimicrobial activities (Kurylo&#x02010;Borowska and Szer, <xref rid="mbt213825-bib-0019" ref-type="bibr">1972</xref>; Pioletti <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0029" ref-type="bibr">2001</xref>). In addition, edeines have been widely used as transcriptional inhibitors to study ribosomal function and protein synthesis (Polikanov <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0030" ref-type="bibr">2018</xref>). However, use of edeines as drugs in human and animals is limited due to their toxicity in animal models (Czajgucki <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0005" ref-type="bibr">2007</xref>). The continuous emergence of multi&#x02010;drug resistant pathogens is a great challenge to public health, which highlights the re&#x02010;investigation of obsolete antibiotics such as edeines for new medical applications (Kiero&#x00144;ska <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0016" ref-type="bibr">1976</xref>; Szaflarski <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0034" ref-type="bibr">2008</xref>).</p><fig position="float" fig-type="Fig." id="mbt213825-fig-0001"><label>Fig. 1</label><caption><p>Chemical structures of edeines A, B, D, and F.</p><p>Edeines have two isomers: <italic toggle="yes">&#x003b1;</italic> (1) and <italic toggle="yes">&#x003b2;</italic> (2). The <italic toggle="yes">&#x003b1;</italic>&#x02010;amino group of DAPA is linked to <italic toggle="yes">&#x003b2;</italic>&#x02010;serine to form the active isomer <italic toggle="yes">&#x003b1;,</italic> while the <italic toggle="yes">&#x003b2;</italic>&#x02010;amino group of DAPA in the inactive isomer is linked to a <italic toggle="yes">&#x003b2;</italic>&#x02010;serine. DAPA, 2,3&#x02010;diaminopropionic acid; DAHAA, 2,6&#x02010;diamino&#x02010;7&#x02010;hydroxyazaleic acid.</p></caption><graphic xlink:href="MBT2-15-577-g006" position="anchor" id="jats-graphic-3"/></fig><p>Edeines are pentapeptides with a unique backbone, composed of a glycine, four nonproteinogenic amino acids and a C&#x02010;terminal polyamine (spermidine in edeine A<sub>1</sub> and guanyl&#x02010;spermidine in edeine B<sub>1</sub>) (Fig.&#x02009;<xref rid="mbt213825-fig-0001" ref-type="fig">1</xref>) (Mazerski <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0023" ref-type="bibr">1981</xref>; Czerwinski <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0006" ref-type="bibr">1983</xref>; Gumieniak <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0010" ref-type="bibr">1983</xref>). The biosynthesis of natural products has advantages over chemical synthesis in laboratories due to its low cost and high intensity (Kunga Sugumaran <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0018" ref-type="bibr">2016</xref>). <italic toggle="yes">B. brevis</italic> X23, an excellent biocontrol agent isolated by our lab (Chen <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0003" ref-type="bibr">2012</xref>), can produce edeines A<sub>1</sub> and B<sub>1</sub> under propriate conditions (Lu, <xref rid="mbt213825-bib-0021" ref-type="bibr">2014</xref>). A previous study has demonstrated broad inhibitory activities of edeines A<sub>1</sub> and B<sub>1</sub> against a large number of plant pathogens (Lu, <xref rid="mbt213825-bib-0021" ref-type="bibr">2014</xref>). While the production of edeines in <italic toggle="yes">B. brevis</italic> X23 could be slightly improved through optimization of media (data not shown), the low yield of edeines produced by <italic toggle="yes">B. brevis</italic> limits their broad application in agriculture as microbicides.</p><p>Genetic engineering, such as promoter modification, deletion or overexpression of regulatory factors, feeding with key precursors and increasing BGC copy number, has significantly improved the production of antibiotics (Marahiel <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0022" ref-type="bibr">1987</xref>; Keeney <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0015" ref-type="bibr">2008</xref>; Zhang <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0045" ref-type="bibr">2016</xref>; Zhang <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0043" ref-type="bibr">2019</xref>). Promoter engineering (native promoter replacement with stronger ones) is one of the most effective ways to improve antibiotic production. The strong promoters P<sub>43</sub>, P<sub>glv</sub> and P<sub>luxS</sub> improved the yield of sublancin in <italic toggle="yes">Bacillus subtilis</italic> 1A747 by 11.5&#x02010;fold (Ji <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0012" ref-type="bibr">2015</xref>). Production of surfactin in <italic toggle="yes">B</italic>. <italic toggle="yes">subtilis</italic> fmbR was increased by 10.2&#x02010;fold by replacing the original promoter of surfactin BGC with the inducible promoter P<sub>spac</sub> (Sun <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0033" ref-type="bibr">2009</xref>).</p><p>Studies examining the biosynthetic pathway of edeines were initiated in the 1960s. Borowska <italic toggle="yes">et&#x000a0;al</italic>. hypothesized that edeines were synthesized by non&#x02010;ribosomal peptide synthetases (NRPSs; Borowska and Tatum, <xref rid="mbt213825-bib-0002" ref-type="bibr">1966</xref>). However, this hypothesis was not confirmed for decades. Based on genome sequencing and bioinformatics analyses, Westman <italic toggle="yes">et&#x000a0;al</italic>. recently identified a hybrid NRPS&#x02010;PKS BGC that is likely to be responsible for the biosynthesis of edeines in <italic toggle="yes">B. brevis</italic> Vm4 (Westman <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0037" ref-type="bibr">2013</xref>). The predicted <underline underline-style="single">ede</underline>ine <underline underline-style="single">b</underline>iosynthetic <underline underline-style="single">g</underline>ene <underline underline-style="single">c</underline>luster (<italic toggle="yes">ede</italic> BGC) encodes four NRPSs and one hybrid PKS&#x02013;NRPS, which is consistent with the pentapeptide structure of edeines. Additionally, the <italic toggle="yes">edeQ</italic> gene on the <italic toggle="yes">ede</italic> BGC was verified to be the self&#x02010;resistance gene because its product, EdeQ, could convert edeine to inactive <italic toggle="yes">N</italic>&#x02010;acetyledeine <italic toggle="yes">in&#x000a0;vitro</italic>. However, the <italic toggle="yes">ede</italic> BGC has not been experimentally confirmed in <italic toggle="yes">B</italic>. <italic toggle="yes">brevis</italic> due to difficulties associated with the genetic manipulation of this organism. To confirm and characterize the <italic toggle="yes">ede</italic> BGC, we initially cloned the predicted <italic toggle="yes">ede</italic> BGC (45.1&#x02009;kb) from <italic toggle="yes">B. brevis</italic> X23 and integrated it into the chromosome of <italic toggle="yes">B</italic>. <italic toggle="yes">subtilis</italic> via Red/ET recombination (Liu <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0020" ref-type="bibr">2016</xref>). However, edeine was not detected in the culture of the genetically modified <italic toggle="yes">B. subtilis</italic>. We recently successfully established a stable genetic manipulation system for <italic toggle="yes">B. brevis</italic> X23 and improved edeine production by disrupting the regulatory factor AbrB (Zhang <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0044" ref-type="bibr">2020</xref>).</p><p>In the present study, we confirmed the <italic toggle="yes">ede</italic> BGC of <italic toggle="yes">B. brevis</italic> X23 by gene disruption and increased the production of edeines A and B by 3.6&#x02009;&#x000b1;&#x02009;0.1 to 8.7&#x02009;&#x000b1;&#x02009;0.7&#x02010;fold by replacing the original promoters of the <italic toggle="yes">ede</italic> operon with six stronger promoters. The highest yields of edeines A and B were obtained in <italic toggle="yes">B. brevis</italic> X23 isolated with P<sub>mwp</sub> promoter replacement. To the best of our knowledge, this is the first study to demonstrate the enhancement of edeine production in <italic toggle="yes">B. brevis</italic> via promoter engineering.</p></sec><sec sec-type="results" id="mbt213825-sec-0002"><title>Results</title><sec id="mbt213825-sec-0003"><title>Identification and characterization of <italic toggle="yes">ede</italic> BGC in <italic toggle="yes">B.&#x02009;brevis</italic> X23</title><p>
<italic toggle="yes">Brevibacillus brevis</italic> X23 was initially isolated in our lab as a biocontrol agent (Table&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S1</xref>), which produces edeines A and B against the plant pathogen causing tobacco bacteria wilt (Lu, <xref rid="mbt213825-bib-0021" ref-type="bibr">2014</xref>). The genome of <italic toggle="yes">B. brevis</italic> X23 was sequenced on the PacBio sequencing platform and submitted to NCBI (accession number: NZ_CP023474.1) (Chen <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0003" ref-type="bibr">2012</xref>). Based on antiSMASH (Blin <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0001" ref-type="bibr">2017</xref>) and Big&#x02010;SCAPE (Navarro&#x02010;Mu&#x000f1;oz <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0026" ref-type="bibr">2020</xref>) analyses, 12 potential secondary metabolite BGCs were identified, one of which showed high sequence similarity to the predicted <italic toggle="yes">ede</italic> BGC of <italic toggle="yes">B. brevis</italic> Vm4 reported by Westman <italic toggle="yes">et&#x000a0;al</italic>., (<xref rid="mbt213825-bib-0037" ref-type="bibr">2013</xref>) (Fig.&#x02009;<xref rid="mbt213825-fig-0002" ref-type="fig">2A</xref>). The identified <italic toggle="yes">ede</italic> BGC in <italic toggle="yes">B. brevis</italic> X23 shared the same organization as that in the <italic toggle="yes">B. brevis</italic> Vm4 genome. Briefly, the <italic toggle="yes">ede</italic> BGC (45.1&#x02009;kb) in <italic toggle="yes">B. brevis</italic> X23 consisted of 17 open reading frames, designated <italic toggle="yes">edeA</italic> to <italic toggle="yes">edeQ</italic> according to the homologous sequences in <italic toggle="yes">B. brevis</italic> Vm4 (Fig.&#x02009;<xref rid="mbt213825-fig-0002" ref-type="fig">2A</xref>).</p><fig position="float" fig-type="Fig." id="mbt213825-fig-0002"><label>Fig. 2</label><caption><p>Antimicrobial activity and HPLC&#x02010;MS analysis of X23&#x02010;WT and X23&#x00394;<italic toggle="yes">ede</italic> strains.</p><p>A. Comparison of the <italic toggle="yes">ede</italic> BGC between <italic toggle="yes">B. brevis</italic> Vm4 (upper panel, form <italic toggle="yes">edeA</italic> to <italic toggle="yes">edeQ</italic>) and <italic toggle="yes">B. brevis</italic> X23 (lower panel, from locus RS18470 to locus RS18550). The sequences were compared by NCBI BLAST analysis. The percentage identity is displayed between homologous genes.</p><p>B. Construction and confirmation of <italic toggle="yes">ede</italic> BGC disruption in <italic toggle="yes">B. brevis</italic> X23. The temperature&#x02010;sensitive knockout vector was constructed via Red/ET recombination, and then the vector was transformed into <italic toggle="yes">B. brevis</italic> X23 by electroporation. The <italic toggle="yes">ede</italic> BGC was disrupted with the apramycin resistance gene (<italic toggle="yes">Apr<sup>R</sup>
</italic>) through double&#x02010;crossover homologous recombination. X23&#x02010;WT indicates the wild type strain of <italic toggle="yes">B. brevis</italic> X23. X23&#x00394;<italic toggle="yes">ede</italic> indicates the <italic toggle="yes">ede</italic> BGC disruption strain of <italic toggle="yes">B. brevis</italic> X23. P1 to P4 indicate the detection primer for the colony PCR to detect correct transformants.</p><p>C. Confirmation of the appropriate transformant of the <italic toggle="yes">ede</italic> BGC disruption <italic toggle="yes">B. brevis</italic> strains by PCR. M, DL 5000 marker; N, X23&#x02010;WT; 1&#x02013;3, transformant 1&#x02013;3; P1/P4: PCR products using primer pairs P1/P4 (3.0&#x02009;kb); P1/P3: PCR products using primer pairs P1/P3 (2.2&#x02009;kb); P2/P4: PCR products using primer pairs P2/P4 (2.2&#x02009;kb).</p><p>D. Antimicrobial activity assays of the fermentation broth of X23&#x02010;WT and X23&#x00394;<italic toggle="yes">ede</italic> strains against <italic toggle="yes">B. subtilis</italic> (1) and <italic toggle="yes">R. solanacearum</italic> (2).</p><p>E. HPLC&#x02010;MS analysis (extracted ion chromatogram (EIC) 750&#x02010;800), showing edeine A and B retention times at 1.2 and 1.5&#x02009;min respectively (dotted lines); &#x02460;, edeine A; &#x02461;, edeine B.</p><p>F. Mass spectrogram of edeines A and B, in which the molecular ions [M&#x02009;+&#x02009;H]<sup>+</sup> were 755.4415 and 797.4623 respectively.</p></caption><graphic xlink:href="MBT2-15-577-g008" position="anchor" id="jats-graphic-5"/></fig><p>While the <italic toggle="yes">ede</italic> BGC was identified in <italic toggle="yes">B. brevis</italic> Vm4 based on bioinformatics prediction (Westman <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0037" ref-type="bibr">2013</xref>), no functional studies have yet been conducted. To confirm whether the predicted <italic toggle="yes">ede</italic> BGC was responsible for the biosynthesis of edeines, we knocked out the promoter region and the starter module <italic toggle="yes">edeP</italic> (RS18545) of the <italic toggle="yes">ede</italic> operon to generate the mutant strain <italic toggle="yes">B. brevis</italic> X23<italic toggle="yes">&#x00394;ede</italic> (Fig.&#x02009;<xref rid="mbt213825-fig-0002" ref-type="fig">2B and C</xref>). Then, both the wild&#x02010;type X23 (X23&#x02010;WT) and mutant strains were subjected to antimicrobial activity and comparative metabolomic analyses. The X23&#x02010;WT strain exhibited considerable antimicrobial activities against <italic toggle="yes">Ralstonia solanacearum</italic> and <italic toggle="yes">B. subtilis</italic> in the plate assay. However, the X23<italic toggle="yes">&#x00394;ede</italic> culture supernatant had completely lost antimicrobial ability against <italic toggle="yes">R</italic>. <italic toggle="yes">solanacearum</italic> (Fig.&#x02009;<xref rid="mbt213825-fig-0002" ref-type="fig">2D</xref>&#x02010;1) and <italic toggle="yes">B. subtilis</italic> (Fig.&#x02009;<xref rid="mbt213825-fig-0002" ref-type="fig">2D</xref>&#x02010;2). High&#x02010;performance liquid chromatography&#x02010;mass spectrometry (HPLC&#x02010;MS) analysis demonstrated abolished production of edeines A and B in the crude extract of the supernatant of X23<italic toggle="yes">&#x00394;ede</italic> culture compared with X23&#x02010;WT (Fig.&#x02009;<xref rid="mbt213825-fig-0002" ref-type="fig">2E and F</xref>). Taken together, these results suggested that the identified <italic toggle="yes">ede</italic> BGC was responsible for the production of antibiotic edeines A and B in <italic toggle="yes">B. brevis</italic> X23.</p></sec><sec id="mbt213825-sec-0004"><title>Construction of promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> X23 strains</title><p>The present study showed that all the edeine biosynthetic genes in <italic toggle="yes">B. brevis</italic> Vm4 (<italic toggle="yes">edeA</italic>&#x02010;<italic toggle="yes">edeP</italic>) were present on the same <italic toggle="yes">ede</italic> operon, which shared a single promoter, P<sub>ede</sub> (Fig.&#x02009;<xref rid="mbt213825-fig-0003" ref-type="fig">3</xref>). Therefore, we hypothesized that it would be possible to improve the expression of the edeine BGC by replacing the original promoter P<sub>ede</sub> with stronger promoters. Thus, six strong promoters that are commonly used in <italic toggle="yes">B. brevis</italic> and <italic toggle="yes">B. subtilis</italic>, including three constitutive promoters (P<sub>shuttle&#x02010;09</sub> (Yang <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0039" ref-type="bibr">2013</xref>), P43 (Ye <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0041" ref-type="bibr">1999</xref>) and P<sub>mwp</sub> (Mizukami <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0024" ref-type="bibr">2010</xref>)) and three inducer&#x02010;free promoters from inducible promoters (P<sub>xylA</sub> (Kim <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0017" ref-type="bibr">1996</xref>), P<sub>grac</sub> (Phan <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0028" ref-type="bibr">2006</xref>) and P<sub>spc</sub> (Yansura and Henner, <xref rid="mbt213825-bib-0040" ref-type="bibr">1984</xref>)) generated by removing the repressor protein component, were selected to replace the original P<sub>ede</sub> promoter to improve edeine production (Tables <xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S2 and S3</xref>). By double&#x02010;crossover homologous recombination via temperature&#x02010;sensitive integration vectors (Fig.&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S1</xref>) carrying the homologous regions from upstream and downstream of the P<sub>ede</sub> region of X23&#x02010;WT, the original promoter P<sub>ede</sub> was replaced with either one of the abovementioned six promoters (Fig.&#x02009;<xref rid="mbt213825-fig-0003" ref-type="fig">3</xref>). The transformants were first identified by PCR (Fig.&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S2</xref>) and confirmed by DNA sequencing. The transformants were designated X23 (P<sub>ede</sub>::P<sub>mwp</sub>), X23 (P<sub>ede</sub>::P<sub>xylA</sub>), X23 (P<sub>ede</sub>::P<sub>43</sub>), X23 (P<sub>ede</sub>::P<sub>shuttle&#x02010;09</sub>), X23 (P<sub>ede</sub>::P<sub>grac</sub>) and X23 (P<sub>ede</sub>::P<sub>spc</sub>).</p><fig position="float" fig-type="Fig." id="mbt213825-fig-0003"><label>Fig. 3</label><caption><p>Schematic diagram of promoter engineering of the <italic toggle="yes">ede</italic> BGC in X23&#x02010;WT. A temperature&#x02010;sensitive knock&#x02010;in vector was constructed using Red/ET recombination. LLHR is the abbreviation of <underline underline-style="single">l</underline>inear to <underline underline-style="single">l</underline>inear <underline underline-style="single">h</underline>omologous <underline underline-style="single">r</underline>ecombination. The homologous arms on the vector cross&#x02010;exchange with homologous sequences on the genome of <italic toggle="yes">B. brevis</italic> X23. The promoter&#x02010;engineered strain was generated. P<sub>ede</sub> indicates the promoter of the <italic toggle="yes">ede</italic> BGC. P<sub>candidate</sub> indicates the six substituted promoters. X23(P<sub>ede</sub>::P<sub>candidate</sub>) is the promoter&#x02010;engineered strain of <italic toggle="yes">B. brevis</italic> X23. P5 to P8 indicate the detection primer for the colony PCR to detect correct transformants.</p></caption><graphic xlink:href="MBT2-15-577-g005" position="anchor" id="jats-graphic-7"/></fig></sec><sec id="mbt213825-sec-0005"><title>Promoter substitutions affected the growth of <italic toggle="yes">B. brevis</italic> X23</title><p>To evaluate the effects of promoter substitution on the growth of <italic toggle="yes">B. brevis</italic>, we compared the growth curves of the X23&#x02010;WT and its six promoter&#x02010;engineered strains by measuring the OD<sub>600</sub> of the corresponding culture broths every 12&#x02009;h (Fig.&#x02009;<xref rid="mbt213825-fig-0004" ref-type="fig">4A</xref>). No significant difference in cell density was identified between the transformants and the X23&#x02010;WT strain at 12&#x02009;h (exponential phase) and 24&#x02009;h (stationary phase) of cultivation. However, the cell turbidity (OD<sub>600</sub>) of the six promoter&#x02010;engineered strains was 7.5&#x02013;15.3% lower than that of the X23&#x02010;WT at 36 and 48&#x02009;h (decline phase) (Fig.&#x02009;<xref rid="mbt213825-fig-0004" ref-type="fig">4B</xref>), suggesting that the promoter substitution affected both the growth and biomass of <italic toggle="yes">B. brevis</italic> X23. The results also revealed that the increased antimicrobial activity observed was not due to the biomass increment.</p><fig position="float" fig-type="Fig." id="mbt213825-fig-0004"><label>Fig. 4</label><caption><p>Growth curves of X23&#x02010;WT and promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains.</p><p>A. Growth curves of the promoter&#x02010;engineered strains and X23&#x02010;WT from 0 to 48&#x02009;h.</p><p>B. Significance of the growth curves at 36&#x02009;h. Different letters indicate statistically significant differences (<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05). P<sub>ede</sub> indicates the promoter of <italic toggle="yes">ede</italic> BGC. X23&#x02010;WT, <italic toggle="yes">B. brevis</italic> X23. X23(P<sub>ede</sub>::P<sub>mwp</sub>), the promoter&#x02010;engineered strain in which P<sub>ede</sub> was replaced by P<sub>mwp</sub>. X23(P<sub>ede</sub>::P<sub>spc</sub>), the promoter&#x02010;engineered strain in which P<sub>ede</sub> was replaced by P<sub>spc</sub>. X23(P<sub>ede</sub>::P<sub>grac</sub>), the promoter&#x02010;engineered strain in which P<sub>ede</sub> was replaced by P<sub>grac</sub>. X23(P<sub>ede</sub>::P<sub>shuttle&#x02010;09</sub>), the promoter&#x02010;engineered strain in which P<sub>ede</sub> was replaced by P<sub>shuttle&#x02010;09</sub>. X23(P<sub>ede</sub>::P<sub>43</sub>), the promoter&#x02010;engineered strain in which P<sub>ede</sub> was replaced by P<sub>43</sub>. X23(P<sub>ede</sub>::P<sub>xylA</sub>), the promoter&#x02010;engineered strain in which P<sub>ede</sub> was replaced by P<sub>xylA</sub>.</p></caption><graphic xlink:href="MBT2-15-577-g007" position="anchor" id="jats-graphic-9"/></fig></sec><sec id="mbt213825-sec-0006"><title>Promoter substitutions significantly improved the antibacterial activity of <italic toggle="yes">B. brevis</italic> X23</title><p>Given that <italic toggle="yes">ede</italic> BGC disruption abolished the antibacterial activity of <italic toggle="yes">B. brevis</italic>, we speculated that edeines were the major antibacterial substances in fermentation supernatants of X23&#x02010;WT when cultured in NB media. Thus, the yield of edeines was roughly consistent with the antimicrobial activity of <italic toggle="yes">B. brevis</italic> X23. Although edeines have broad inhibitory activity against Gram&#x02010;positive and Gram&#x02010;negative bacteria, <italic toggle="yes">B. subtilis</italic> was chosen to evaluate the antibacterial activity of all <italic toggle="yes">B. brevis</italic> strains because it exhibited the highest sensitivity to edeines based on our previous results (Lu, <xref rid="mbt213825-bib-0021" ref-type="bibr">2014</xref>). Therefore, to evaluate the effects of promoter substitutions on the yield of edeines, we first performed plate inhibition assay to assess the antibacterial activity of X23&#x02010;WT and six promoter&#x02010;engineered strains against <italic toggle="yes">B. subtilis</italic> 168 after 6, 9, 12, 24, 36 and 48&#x02010;h incubations. The results showed an increased radius of the inhibition zone for all six promoter&#x02010;engineered strains compared with X23&#x02010;WT (Fig.&#x02009;<xref rid="mbt213825-fig-0005" ref-type="fig">5A</xref>). After 48&#x02009;h of incubation, the radii of the inhibitory zones of X23(P<sub>ede</sub>::P<sub>mwp</sub>), X23(P<sub>ede</sub>::P<sub>grac</sub>), X23(P<sub>ede</sub>::P<sub>shuttle&#x02010;09</sub>), X23(P<sub>ede</sub>::P<sub>spc</sub>), X23(P<sub>ede</sub>::P<sub>xylA</sub>) and X23(P<sub>ede</sub>::P<sub>43</sub>) were increased by 1.3&#x02009;&#x000b1;&#x02009;0.2, 1.2&#x02009;&#x000b1;&#x02009;0.2, 1.1&#x02009;&#x000b1;&#x02009;0.2, 1.0&#x02009;&#x000b1;&#x02009;0.1, 1.0&#x02009;&#x000b1;&#x02009;0.2 and 0.9&#x02009;&#x000b1;&#x02009;0.1&#x02010;fold, respectively, compared with the X23&#x02010;WT strain (Fig.&#x02009;<xref rid="mbt213825-fig-0005" ref-type="fig">5B and C</xref>). Of note, there was no significant difference in the radius of inhibition zone between the promoter&#x02010;engineered X23(P<sub>ede</sub>::P<sub>mwp</sub>) and X23(P<sub>ede</sub>::P<sub>grac</sub>) strains. Taken together, these results showed that promoter substitutions improved the antibacterial activity of <italic toggle="yes">B. brevis</italic> X23 against <italic toggle="yes">B. subtilis</italic> 168, and promoters P<sub>mwp</sub> and P<sub>grac</sub> achieved the highest antimicrobial activities among the six promoters. The results also suggested that the promoter&#x02010;engineered strains produced antimicrobial substances earlier than X23&#x02010;WT.</p><fig position="float" fig-type="Fig." id="mbt213825-fig-0005"><label>Fig. 5</label><caption><p>Antibacterial ability of X23&#x02010;WT and promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains.</p><p>A. Bacteriostatic ability curve of the fermentation broth of X23&#x02010;WT and promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains after incubation from 6 to 48&#x02009;h.</p><p>B. Significance of the differences between bacteriostatic radii at 48&#x02009;h. Different letters indicate statistically significant differences (<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05).</p><p>C. Plate&#x000a0;antimicrobial assays of fermentation broth of the promoter&#x02010;engineered strains (periphery) and X23&#x02010;WT(center) against <italic toggle="yes">B. subtilis</italic> incubation for 48&#x02009;h. All broths were diluted five times, and 10&#x02009;&#x003bc;l of each dilution was added to the center of the paper disk. Experiments were performed in triplicate.</p></caption><graphic xlink:href="MBT2-15-577-g004" position="anchor" id="jats-graphic-11"/></fig></sec><sec id="mbt213825-sec-0007"><title>Promoter substitutions significantly increased the expression of <italic toggle="yes">ede</italic> BGC</title><p>To evaluate the effects of promoter substitutions on the expression of <italic toggle="yes">ede</italic> BGC, we assessed the transcriptional level of <italic toggle="yes">edeP</italic> gene based on quantitative real&#x02010;time PCR (qRT&#x02010;PCR). Compared with X23&#x02010;WT, significantly increased expression of <italic toggle="yes">ede</italic> BGC was detected in the six promoter&#x02010;engineered strains with <italic toggle="yes">ede</italic> promoter substitutions after 12, 24 and 36&#x02009;h of culture (Fig.&#x02009;<xref rid="mbt213825-fig-0006" ref-type="fig">6</xref>).</p><fig position="float" fig-type="Fig." id="mbt213825-fig-0006"><label>Fig. 6</label><caption><p>Relative expression of <italic toggle="yes">edeP</italic> on the <italic toggle="yes">ede</italic> BGC from various promoter&#x02010;engineered strains and X23&#x02010;WT at 12, 24, and 36&#x02009;h as measured by qRT&#x02010;PCR. The cells of different strains were cultured in NB and incubated at 30&#x000b0;C for 12, 24, and 36&#x02009;h. Total RNA was isolated for qRT&#x02010;PCR assays. X23&#x02010;WT was used as the control. The 16S rRNA was used for data normalization. Experiments were performed in triplicate.</p></caption><graphic xlink:href="MBT2-15-577-g002" position="anchor" id="jats-graphic-13"/></fig><p>In the early growth stage (12&#x02009;h), the level of <italic toggle="yes">ede</italic> BGC transcription in X23&#x02010;WT was extremely low because the expression of secondary metabolites such as edeines was repressed during the primary metabolic period by the global regulatory systems. In contrast, <italic toggle="yes">ede</italic> BGC expression in the promoter&#x02010;engineered strains was not limited by these regulatory systems, resulting in 2.9&#x02009;&#x000b1;&#x02009;0.4 to 20.5&#x02009;&#x000b1;&#x02009;1.2&#x02010;fold higher expression of the <italic toggle="yes">ede</italic> BGC in the early stage compared with X23&#x02010;WT. The highest (15.4&#x02009;&#x000b1;&#x02009;1.9&#x02010;fold compared with X23&#x02010;WT) level of <italic toggle="yes">ede</italic> BGC expression after 12&#x02009;h of culture was detected in X23(P<sub>ede</sub>::P<sub>mwp</sub>). In the middle stage (24&#x02009;h), expression of the <italic toggle="yes">ede</italic> BGC in X23&#x02010;WT was increased by 3.6&#x02009;&#x000b1;&#x02009;0.8&#x02010;fold compared with that at 12&#x02009;h. The highest (14.6&#x02009;&#x000b1;&#x02009;1.0&#x02010;fold compared with X23&#x02010;WT) expression of <italic toggle="yes">ede</italic> BGC was detected in X23(P<sub>ede</sub>::P<sub>grac</sub>) after 24&#x02009;h of culture.</p><p>In the late period (36&#x02009;h), expression of the <italic toggle="yes">ede</italic> BGC in X23&#x02010;WT rapidly decreased to 0.4&#x02009;&#x000b1;&#x02009;0.1 (compared with that at 12&#x02009;h), while in the six promoter&#x02010;engineered strains, it was still 3.1&#x02009;&#x000b1;&#x02009;0.2 to 20.5&#x02009;&#x000b1;&#x02009;1.2&#x02010;fold higher than that in X23&#x02010;WT. The highest (20.5&#x02009;&#x000b1;&#x02009;1.2&#x02010;fold compared with X23&#x02010;WT) expression of <italic toggle="yes">ede</italic> BGC was detected in X23(P<sub>ede</sub>::P<sub>grac</sub>).</p><p>Taken together, these results showed that expression of the <italic toggle="yes">ede</italic> BGC was significantly increased by the promoter substitutions, and promoters P<sub>mwp</sub> and P<sub>grac</sub> provided the highest expression of the <italic toggle="yes">ede</italic> BGC.</p></sec><sec id="mbt213825-sec-0008"><title>Quantitative analysis of edeine production in promoter&#x02010;engineered strains by HPLC&#x02010;MS analysis</title><p>While the promoter substitutions were associated with improved antibacterial activity of <italic toggle="yes">B. brevis</italic> X23, it was not clear whether the improved antibacterial activity was due to increased production of edeines. We compared the production of edeines between the X23&#x02010;WT and promoter&#x02010;engineered strains based on HPLC&#x02013;MS analysis (Fig.&#x02009;<xref rid="mbt213825-fig-0007" ref-type="fig">7A and B</xref>).</p><fig position="float" fig-type="Fig." id="mbt213825-fig-0007"><label>Fig. 7</label><caption><p>Detection and analysis of edeines of the X23&#x02010;WT and promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains by HPLC&#x02010;MS.</p><p>A. Comparison of edeine yield between X23&#x02010;WT and promoter&#x02010;engineered strains. The HPLC&#x02010;MS analysis retention times of edeines A and B were 1.2 and 1.5&#x02009;min respectively (indicated by arrows).</p><p>B. Mass spectrogram of edeines A and B. According to the mass spectrogram of edeines A and B, the molecular ions [M&#x02009;+&#x02009;H]<sup>+</sup> were 755.4413 and 797.4635 respectively.</p><p>C. Yield changes of edeines A and B of theX23&#x02010;WT and promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains. Data are presented as averages of three independent experiments. Error bars indicate standard deviations (SD). Different letters indicate statistically significant differences (<italic toggle="yes">P</italic>&#x02009;&#x0003c;&#x02009;0.05).</p></caption><graphic xlink:href="MBT2-15-577-g001" position="anchor" id="jats-graphic-15"/></fig><p>We purified edeines A and B from the culture broth of <italic toggle="yes">B. brevis</italic> X23 because the standard compounds are not commercially available. HPLC and high&#x02010;resolution mass spectrometry (HRMS) were conducted to determine the purity of edeines A and B (Figs <xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S3 and S4</xref>). The structure of edeine A was confirmed by nuclear magnetic resonance (NMR) spectroscopy (Figs <xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S5 and S6</xref>). We further determined the absolute yield of edeines A and B using standard curve&#x02010;based quantitative analysis (Fig.&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S7</xref>). As shown in Fig.&#x02009;<xref rid="mbt213825-fig-0007" ref-type="fig">7C</xref>, the amounts of edeines A and B were significantly higher in the fermentation broth of promoter&#x02010;engineered strains compared with X23&#x02010;WT after 48&#x02009;h of culture, which was consistent with the antimicrobial activity assays. Compared with X23&#x02010;WT, the yields of edeines A and B produced by X23(P<sub>ede</sub>::P<sub>mwp</sub>), X23(P<sub>ede</sub>::P<sub>grac</sub>), X23(P<sub>ede</sub>::P<sub>shuttle&#x02010;09</sub>), X23(P<sub>ede</sub>::P<sub>spc</sub>), X23(P<sub>ede</sub>::P<sub>xylA</sub>) and X23(P<sub>ede</sub>::P<sub>43</sub>) were increased by 8.7&#x02009;&#x000b1;&#x02009;0.6, 8.0&#x02009;&#x000b1;&#x02009;0.3, 4.4&#x02009;&#x000b1;&#x02009;0.5, 7.2&#x02009;&#x000b1;&#x02009;0.6, 7.9&#x02009;&#x000b1;&#x02009;0.4 and 3.6&#x02009;&#x000b1;&#x02009;0.1&#x02010;fold respectively (Fig.&#x02009;<xref rid="mbt213825-fig-0007" ref-type="fig">7C</xref> and Table&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S4</xref>). The highest yield of edeine A (83.4&#x02009;mg&#x02009;l<sup>&#x02212;1</sup>) was detected in X23(P<sub>ede</sub>::P<sub>mwp</sub>) compared with the X23&#x02010;WT strain (9.4&#x02009;mg&#x02009;l<sup>&#x02212;1</sup>), which was consistent with the antimicrobial test and gene expression of the <italic toggle="yes">ede</italic> BGC (Table&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S4</xref>). In contrast, an increased yield of edeine B was only detected in X23(P<sub>ede</sub>::P<sub>xylA</sub>) (0.3&#x02009;mg&#x02009;l<sup>&#x02212;1</sup>) compared with the X23&#x02010;WT strain (0.2&#x02009;mg&#x02009;l<sup>&#x02212;1</sup>). The total yield of edeines (edeine A and B) reached 83.59&#x02009;mg&#x02009;l<sup>&#x02212;1</sup> in X23(P<sub>ede</sub>::P<sub>mwp</sub>) (Table&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S4</xref>). Given that the yield of edeine B was much lower than that of edeine A and that edeine B contains an unusual guanyl&#x02010;spermidine reside rather than spermidine, we speculated that the availability of the precursor guanyl&#x02010;spermidine might limit edeine B production.</p></sec></sec><sec sec-type="discussion" id="mbt213825-sec-0009"><title>Discussion</title><p>Although edeines were identified over 60&#x02009;years ago, the biosynthetic pathway of edeines has remained ambiguous, thus limiting improvements of edeines yield through biosynthetic pathway modification. Westman <italic toggle="yes">et&#x000a0;al</italic>. first identified the <italic toggle="yes">ede</italic> BGC in the <italic toggle="yes">B. brevis</italic> Vm4 genome based on genomic analyses (Westman <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0037" ref-type="bibr">2013</xref>). In this study, we confirmed the functionality of the <italic toggle="yes">ede</italic> BGC in <italic toggle="yes">B. brevis</italic> X23 through gene disruption. Identification and confirmation of the <italic toggle="yes">ede</italic> BGC allowed us to significantly improve the production of edeines through promoter engineering.</p><p>We replaced the original promoter of the <italic toggle="yes">ede</italic> BGC with stronger constitutive promoters to increase expression of the <italic toggle="yes">ede</italic> BGC and improve edeine production. Transcriptomic analyses (data not shown) and the RT&#x02010;PCR assay (Fig.&#x02009;<xref rid="mbt213825-fig-0006" ref-type="fig">6</xref>) indicated that the original promoter of <italic toggle="yes">ede</italic> BGC might be controlled by global secondary metabolic regulatory factors, and high&#x02010;level expression of <italic toggle="yes">ede</italic> BGC was not reached until the mid&#x02010;late stage (24&#x02009;h). The three constitutive stronger promoters tested in this study, P<sub>43</sub>, P<sub>mwp</sub> and P<sub>shuttle&#x02010;09</sub>, mediate expression of genes that encode enzymes involved in primary metabolism and cell growth, which are active most of the time and are not controlled by secondary metabolic regulators (Ye <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0041" ref-type="bibr">1999</xref>; Mizukami <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0024" ref-type="bibr">2010</xref>). Therefore, the stronger constitutive promoters significantly increased the expression of <italic toggle="yes">ede</italic> BGC and the antimicrobial activity (edeine production) from the early growth stage.</p><p>Three chemically inducible promoters, including P<sub>xylA</sub>, P<sub>spc</sub> and P<sub>grac</sub>, were also tested in this study. Specific stimuli (xylose for P<sub>xylA</sub>; IPTG for P<sub>spc</sub> and P<sub>grac</sub>) are required to switch on these chemically inducible promoters (Yansura and Henner, <xref rid="mbt213825-bib-0040" ref-type="bibr">1984</xref>; Kim <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0017" ref-type="bibr">1996</xref>; Phan <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0028" ref-type="bibr">2006</xref>), which increases the cost of fermentation. Chemically inducible promoters are usually companied by a regulatory gene encoding a repressor protein that binds to the promoter upstream, blocking the transcription of downstream genes in the absence of inducers. Therefore, chemically inducible promoters may achieve constitutive expression when the repressor gene is disrupted. Tran <italic toggle="yes">et&#x000a0;al</italic>. constructed an inducer&#x02010;free expression plasmid with the IPTG&#x02010;inducible promoter P<sub>grac</sub> for <italic toggle="yes">B. subtilis</italic> by disrupting the repressor <italic toggle="yes">lacI</italic> gene (Tran <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0036" ref-type="bibr">2017</xref>). We constructed a reporter gene plasmid system in <italic toggle="yes">B. brevis</italic> X23&#x02010;WT based on the green fluorescent protein (<italic toggle="yes">gfp</italic>) gene to explore whether the P<sub>xylA</sub>, P<sub>spc</sub> and P<sub>grac</sub> promoters could be transformed into inducer&#x02010;free promoters in <italic toggle="yes">B. brevis</italic>. The results showed that the promoters without repressor genes resulted in constitutive expression of the <italic toggle="yes">gfp</italic> gene in the absence of their inducers (Fig.&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S8</xref>). Subsequently, RT&#x02010;PCR also revealed constitutive expression of the <italic toggle="yes">ede</italic> BGC in <italic toggle="yes">B. brevis</italic> promoter&#x02010;engineered strains containing the P<sub>xylA</sub>, P<sub>spc</sub> or P<sub>grac</sub> promoter throughout the growth period (Fig.&#x02009;<xref rid="mbt213825-fig-0006" ref-type="fig">6</xref>).</p><p>Of the six promoters, the P<sub>mwp</sub> promoter resulted in the most significant expression of the <italic toggle="yes">ede</italic> BGC and the highest edeine production. This impressive power of the P<sub>mwp</sub> promoter in driving the expression of <italic toggle="yes">ede</italic> BGC might be explained as follows. First, the promoter of the cell wall protein gene (HWP) in <italic toggle="yes">B. brevis</italic> HPD31 has long been regarded as an extremely strong promoter in the exponential period, and it is used in the <italic toggle="yes">Brevibacillus</italic> Expression System by TaKaRa Biomedical Technology Co., Ltd (Mizukami <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0024" ref-type="bibr">2010</xref>). This expression system has been widely applied for the robust expression of a large number of genes encoding enzymes, antigens and cytokines, such as <italic toggle="yes">&#x003b1;</italic>&#x02010;amylase, sphingomyelinase, xylanase, surface antigen, epidermal growth factor and interferon&#x02010;<italic toggle="yes">&#x003b3;</italic> (Mizukami <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0024" ref-type="bibr">2010</xref>). The P<sub>mwp</sub> promoter was derived from a middle cell wall protein (MWP) gene, which is the homolog of HWP (78% identity in <italic toggle="yes">B. brevis</italic> X23) (Ebisu <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0007" ref-type="bibr">1990</xref>). Second, based on transcriptomic analyses of <italic toggle="yes">B. brevis</italic> X23 in the exponential growth period, the MWP gene exhibited the highest transcription among all 6291 coding genes. The expression level of the MWP gene was 18.6&#x02009;&#x000b1;&#x02009;0.8&#x02010;fold higher than that of the <italic toggle="yes">ede</italic> BGC (data not shown), suggesting that the MWP promoter is a strong promoter with the potential to improve edeine production in <italic toggle="yes">B. brevis</italic>. Indeed, the P<sub>mwp</sub> promoter increased transcription of <italic toggle="yes">edeP</italic> in <italic toggle="yes">B. brevis</italic> X23 15.4&#x02009;&#x000b1;&#x02009;1.9&#x02010;fold after 12&#x02009;h of incubation, which was consistent with our previous abovementioned observation. Taken together, replacing the original promoter with stronger promoters is an efficient way to improve the production of natural products in bacteria.</p><p>Interestingly, the yield of edeine B was not significantly increased or even decreased after replacing the original promoter with stronger promoters. Previously, Shimotohno <italic toggle="yes">et&#x000a0;al</italic>. identified and purified edeine B<sub>1</sub> amidinohydrolase, which can transform edeine B to edeine A. They speculated that edeine B was the intermediate product of edeine A (Shimotohno <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0032" ref-type="bibr">1999</xref>). This speculation could explain the markedly reduced production of edeine B compared with edeine A or even its decrease following promoter engineering. In addition, edeine B contains an uncommon guanyl&#x02010;spermidine substituted by spermidine. Thus, we speculated that low contents of the guanyl&#x02010;spermidine might limit edeine B production. A number of strategies from previous studies, such as optimization of the culture media, overexpression of the precursor synthesis pathway and modification of regulatory factors (Zhang <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0045" ref-type="bibr">2016</xref>), can be applied to further improve the production of edeine A.</p><p>In this study, we successfully improved edeine A production in <italic toggle="yes">B. brevis</italic> X23 by replacing the original <italic toggle="yes">ede</italic> BGC promoter with strong promoters. Of the six strong promoters, P<sub>mwp</sub> generated the highest yield of edeines (83.6&#x02009;mg&#x02009;l<sup>&#x02212;1</sup>). To the best of our knowledge, this is the first report to examine the improvement of edeine production through genetic modification of the <italic toggle="yes">ede</italic> BGC. Based on these results, we are further exploring the edeine biosynthetic pathway and novel derivatives through structural modifications.</p></sec><sec sec-type="materials-and-methods" id="mbt213825-sec-0010"><title>Materials and methods</title><sec id="mbt213825-sec-0011"><title>Bacterial strains, plasmids and promoters</title><p>All strains and plasmids used in this study are listed in Table&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S1</xref>. The original edeine producer <italic toggle="yes">B. brevis</italic> X23 was isolated from tobacco rhizosphere soil by our laboratory (Chen <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0003" ref-type="bibr">2012</xref>). The primer sequences and characteristics of the six promoters used to replace the original <italic toggle="yes">ede</italic> BGC promoter are shown in Tables <xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S2 and S3</xref>. All primers were synthesized by Sangon Biotech Co., Ltd. (Shanghai, China) (Table&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S5</xref>). All restriction enzymes were purchased from New England Biolabs (Beijing, China). Taq polymerase and DNA marker were purchased from TaKaRa Bio Inc. (Dalian, China).</p><p>The <italic toggle="yes">E.&#x000a0;coli</italic> and <italic toggle="yes">B. brevis</italic> strains were cultured at 37&#x000b0;C or 30&#x000b0;C, respectively, in solid or liquid Luria&#x02010;Bertani (LB) media (Green and Sambrook, <xref rid="mbt213825-bib-0008" ref-type="bibr">2012</xref>) consisting of 1% (w/v) tryptone, 0.5% yeast extract and 1% NaCl. The pH of the LB media was adjusted to 7.0. For solid media, 1.5% (w/v) agar was supplemented. For <italic toggle="yes">E.&#x000a0;coli</italic>, apramycin (20&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup>) and ampicillin (100&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup>) were added to the media as required. Promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains were selected on LB media containing apramycin (10&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup>) and erythromycin (1.5&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup>).</p><p>
<italic toggle="yes">Brevibacillus brevis</italic> strain fermentation cultures consisted of Nutrient&#x02010;Broth (NB) media (Green and Sambrook, <xref rid="mbt213825-bib-0008" ref-type="bibr">2012</xref>) containing 1% (w/v) tryptone, 0.3% beef extract, 0.5% NaCl and 1% glucose. The pH of the NB media was adjusted to 7.0.</p></sec><sec id="mbt213825-sec-0012"><title>Construction of <italic toggle="yes">ede</italic> disruption and promoter&#x02010;substituted mutants of <italic toggle="yes">B. brevis</italic> X23</title><p>Genomic DNA was isolated from <italic toggle="yes">B. brevis</italic> X23 and <italic toggle="yes">B. subtilis</italic> 1A751 using an EZ&#x02010;10 Spin Column Bacterial Genomic DNA Isolation Kit (Sangon Biotech, Shanghai, China). The primers used in this study are shown in Table&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S5</xref>. The upstream and downstream homologous regions were amplified from <italic toggle="yes">B. brevis</italic> X23 using PCR with primers edePC&#x02010;F1/edePC&#x02010;F2 and Pmwp&#x02010;ede&#x02010;R1/edePC&#x02010;R2 respectively. The apramycin resistance gene (Apra<sup>R</sup>) was amplified from the pSET152 vector using PCR with primers Apra1(edePC) and Apra2(edePmwp). The P<sub>mwp</sub> promoter was amplified from <italic toggle="yes">B. brevis</italic> X23 using PCR with primers Pmwp&#x02010;ede&#x02010;1/Pmwp&#x02010;ede&#x02010;2. The P<sub>43</sub> promoter was amplified from <italic toggle="yes">B. subtilis</italic> 1A751 using PCR. Other promoters, including P<sub>grac</sub> (Phan <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0028" ref-type="bibr">2006</xref>), P<sub>spc</sub> (Yansura and Henner, <xref rid="mbt213825-bib-0040" ref-type="bibr">1984</xref>), P<sub>xylA</sub> (Kim <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0017" ref-type="bibr">1996</xref>) and P<sub>43</sub> (Ye <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0041" ref-type="bibr">1999</xref>), were amplified from the different plasmids. The P<sub>shuttle&#x02010;09</sub> was synthesized and cloned into plasmid pUC18 by Hunan Tsingke Biocompany, Ltd. (Changsha, China) according to a previous study (Yang <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0039" ref-type="bibr">2013</xref>).</p><p>Thereafter, the fused fragments of the corresponding promoter and Apra<sup>R</sup> were amplified using overlapping extension PCR with primers Apra1(edePC)/Pmwp&#x02010;ede&#x02010;2 (Yan <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0038" ref-type="bibr">2008</xref>). The pE194 vector backbone was amplified from the temperature&#x02010;sensitive plasmid pBR322&#x02010;ErmB&#x02010;ori194 using primers pE194&#x02010;F/pE194&#x02010;R. Every four fragments (i.e. the promoter&#x02010;Apra<sup>R</sup>, pE194 vector backbone and P<sub>ede</sub> upstream and downstream homologous arms) with 45&#x02010;bp overlapping sequences in both terminal regions were co&#x02010;transformed into GB05dir, an <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> strain LLHR&#x02010;proficient recombinase (RecET, Red<italic toggle="yes">&#x003b3;</italic> and RecA), to construct a promoter&#x02010;substitution plasmid according to previous studies (Yu <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0042" ref-type="bibr">2000</xref>; Zhang <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0046" ref-type="bibr">2000</xref>; Muyrers <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0025" ref-type="bibr">2001</xref>; Sharan <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0031" ref-type="bibr">2009</xref>) (Figs <xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S2 and S3</xref>). Promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains were selected on LB solid media using 20&#x02009;&#x003bc;g&#x02009;ml<sup>&#x02212;1</sup> apramycin. Selected recombinant vectors were confirmed by restriction enzyme digestion and sequencing, namely pE194&#x02010;edePC&#x02010;P<sub>xylA</sub>&#x02010;Apra, pE194&#x02010;edePC&#x02010;Apra&#x02010;P<sub>mwp</sub>, pE194&#x02010;edePC&#x02010;Apra&#x02010;P<sub>shuttle&#x02010;09</sub>, pE194&#x02010;edePC&#x02010;Apra&#x02010;P<sub>grac</sub>, pE194&#x02010;edePC&#x02010;Apra&#x02010;P<sub>spc</sub> and pE194&#x02010;edePC&#x02010;Apra&#x02010;P<sub>43</sub>.</p><p>The six promoter substitution vectors were transferred into <italic toggle="yes">B. brevis</italic> X23 by electroporation according to the previous methods (Takahashi <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0035" ref-type="bibr">1983</xref>; Okamoto <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0027" ref-type="bibr">1997</xref>). After double&#x02010;crossover homologous recombination, the original promoter of <italic toggle="yes">ede</italic> BGC was substituted with each one of the six promoters as illustrated in Fig.&#x02009;<xref rid="mbt213825-fig-0003" ref-type="fig">3</xref>. Recombinants were selected on LB agar containing 10&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup> apramycin and confirmed by PCR amplification with the specific primers on the 5&#x02019;(P1/P2) and 3&#x02019;(P3/P4) ends of the replacement site. The PCR amplicons were sequenced to verify the inserted promoter sequence. The promoter&#x02010;engineered strains were designated as X23(P<sub>ede</sub>::P<sub>mwp</sub>), X23(P<sub>ede</sub>::P<sub>xylA</sub>), X23(P<sub>ede</sub>::P<sub>shuttle&#x02010;09</sub>), X23(P<sub>ede</sub>::P<sub>grac</sub>), X23(P<sub>ede</sub>::P<sub>spc</sub>) and X23(P<sub>ede</sub>::P<sub>43</sub>) respectively.</p></sec><sec id="mbt213825-sec-0013"><title>Assessment of bacterial growth</title><p>The growth curves of the X23&#x02010;WT and six promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains were evaluated according to a previous study (Jung <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0014" ref-type="bibr">2012</xref>). Briefly, a single colony of each strain was cultured in 1.0&#x02009;ml of liquid LB media at 30&#x000b0;C overnight and then transferred into 50&#x02009;ml of fresh liquid fermentation media (NB) to reach an initial optical density (OD<sub>600</sub>) of 0.1 and measured using a spectrophotometer T6 (Puxi, China) every 12&#x02009;h for 48&#x02009;h. The fermentation experiments were repeated three times, and each measurement was performed three times in parallel.</p></sec><sec id="mbt213825-sec-0014"><title>Evaluation of antimicrobial activity</title><p>
<italic toggle="yes">Bacillus subtilis</italic> 168 was used to evaluate the antimicrobial activity of <italic toggle="yes">B</italic>. <italic toggle="yes">brevis</italic> X23 and the six promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains through Kirby&#x02010;Bauer disk diffusion according to a previous study (Gui <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0009" ref-type="bibr">2019</xref>). The <italic toggle="yes">B</italic>. <italic toggle="yes">brevis</italic> culture in liquid NB was collected every 12&#x02013;48&#x02009;h. After centrifugation at 9000&#x02009;<italic toggle="yes">g</italic> for 10&#x02009;min at 4&#x000b0;C, the supernatant was passed through a filter (0.22&#x02009;&#x003bc;m) to obtain a sterile filtrate. <italic toggle="yes">B</italic>. <italic toggle="yes">subtilis</italic> 168 was spread on LB agar plates after dilution to an OD<sub>600</sub> of 0.1. A sterile paper disk with a diameter of 6.0&#x02009;mm was placed on each plate. Each filtrate (10&#x02009;&#x003bc;l) was added to the center of the paper disk. Sterile LB liquid media served as a negative control (Gui <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0009" ref-type="bibr">2019</xref>). The plates were incubated for 24&#x02009;h at 30&#x000b0;C, and the inhibition zone was measured. The antimicrobial activity was evaluated based on comparing the radius of inhibition zone. The tests were repeated three times, with three parallel tests each time.</p></sec><sec id="mbt213825-sec-0015"><title>Evaluation of edeine production through HPLC&#x02013;MS</title><p>To determine the concentration of edeine produced by the X23&#x02010;WT and promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains, edeines were extracted from bacterial culture and analyzed by HPLC&#x02013;MS. Edeines were extracted according to the previous study, with some modifications (Westman <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0037" ref-type="bibr">2013</xref>).</p><p>A 100&#x02010;ml culture of the X23&#x02010;WT or promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains was grown in a 500&#x02010;mL flask at 30&#x000b0;C with rotation (180 r.p.m.) for 48&#x02009;h. The supernatant was obtained by centrifugation at 9000&#x02009;<italic toggle="yes">g</italic> for 10&#x02009;min at 4&#x000b0;C (5910R, Eppendorf), combined with 5&#x02009;ml of WorkBeads&#x02009;100S (Bioworks) and stirred for 2&#x02009;h. The resin was then filtered from the supernatant and packed into a 300/15 column. The column was washed with 200&#x02009;ml of distilled water, and then edeines were eluted with 15&#x02009;ml of ammonium hydroxide (0.1&#x02009;M). The eluents were pooled, lyophilized and redissolved into 1&#x02009;ml of distilled water to obtain the crude edeines extracts for further HPLC analysis. The HPLC system (Agilent 1260) was performed using an ODS column (Agilent XBD&#x02010;C18, 2.1&#x02009;&#x000d7;&#x02009;100&#x02009;mm, 5&#x02009;&#x003bc;m) with gradient elution. The UV spectra were detected on a diode array detector with wavelengths ranging from 200 to 600&#x02009;nm. HPLC parameters were as follows: solvent A, H<sub>2</sub>O with 0.1% TFA; solvent B, methanol; gradient at a constant flow rate of 1&#x02009;ml&#x02009;min<sup>&#x02212;1</sup>; 0&#x02013;18&#x02009;min, 10% B, 18&#x02013;20&#x02009;min, 10&#x02013;95% B, 20&#x02013;22&#x02009;min, 95% B, 22&#x02013;25&#x02009;min, 10% B; detection by UV spectroscopy at 278&#x02009;nm. HPLC&#x02013;MS analyses were performed using quadrupole time&#x02010;of&#x02010;flight mass spectrometry (UPLC&#x02013;QTOF; Agilent 6545) equipped with qualitative analysis software. Mass spectra were acquired in centroid mode ranging from 200 to 1500&#x02009;<italic toggle="yes">m/z</italic> in positive ionization mode with auto MS<sup>2+</sup> fragmentation.</p><p>Edeines A and B were purified according to a previous study (Westman <italic toggle="yes">et&#x000a0;al</italic>., <xref rid="mbt213825-bib-0037" ref-type="bibr">2013</xref>). The purity was determined by HPLC and HPLC&#x02013;MS&#x02013;MS. The structure was determined by NMR spectroscopy with a Bruker Avance 600 spectrometer at 600&#x02009;MHz (<sup>1</sup>H) and 150&#x02009;MHz (<sup>13</sup>C). The standard curves of edeines A and B were established by testing 0.5, 1, 50, 100 and 500&#x02009;&#x003bc;g&#x02009;ml<sup>&#x02212;1</sup> edeine A (EIC 755.4&#x02009;&#x000b1;&#x02009;0.5) and B (EIC 797.4&#x02009;&#x000b1;&#x02009;0.5). The yields of edeines A and B were determined from the peak area (extracted ion chromatogram) by reference to the standard curve.</p></sec><sec id="mbt213825-sec-0016"><title>Extraction of total RNA and quantitative real&#x02010;time PCR</title><p>The mRNA level of the first gene (<italic toggle="yes">edeP</italic>) on the <italic toggle="yes">ede</italic> operon in X23&#x02010;WT and the six promoter&#x02010;engineered <italic toggle="yes">B</italic>. <italic toggle="yes">brevis</italic> strains was determined by RT&#x02010;PCR. Bacterial cells cultivated for 12, 24, 36 and 48&#x02009;h were collected and rinsed twice with physiological saline. Total RNA was isolated from bacterial culture using the EasyPure<sup>&#x000ae;</sup> RNA Kit (TransGen Biotech Co., LTD, China) according to the manufacture&#x02019;s protocol and reverse&#x02010;transcribed into cDNA using the EasyScript<sup>&#x000ae;</sup> One&#x02010;Step gDNA Removal and cDNA Synthesis kit (TransGen Biotech Co., LTD, China).</p><p>We conducted qRT&#x02010;PCR using Fast SYBR Green Master Mix (2&#x000d7; Universal SYBR Green Fast For qPCR Mix, Abclonal, China) and the ABI&#x02010;QS5 Real Time PCR detection system. Gene&#x02010;specific primers were designed using Primer Premier 6.0 (primer sequences are listed in Table&#x000a0;<xref rid="mbt213825-sup-0001" ref-type="supplementary-material">S5</xref>). The fluorescence change in SYBR Green I was monitored by the system software every cycle, and the ROX value was simultaneously used for correction. The threshold cycle (CT), melting curves and relative gene expression levels (&#x02212;&#x00394;<sup>CT</sup>) were automatically measured. The 16S rRNA gene was used as the internal reference gene. Real&#x02010;time PCR assay was repeated three times, and each sample was assessed in triplicate.</p></sec></sec><sec sec-type="COI-statement" id="mbt213825-sec-0018"><title>Conflict of interest</title><p>The authors declare no competing financial interests.</p></sec><sec id="mbt213825-sec-0019"><title>Author contributions</title><p>Q.L., L.Z., Y. W., X.B., W.C., Z.G. and D.L. designed the study; Q.L., L.Z., C.Z., T.L. and C.D. conducted the experiments; Q.L., L.Z., Z.G., Q.L., Y.T., J.D. and W.C. performed the data collection and analyses; Q.L. and L.Z. drafted the manuscript and W.C., X.B., L.D., A.L. and D.L. revised the manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="mbt213825-sup-0001" position="float" content-type="local-data"><caption><p>
<bold>Table&#x000a0;S1</bold>. Strains and plasmids used in this study.</p><p>
<bold>Table&#x000a0;S2</bold>. Characterization of the six promoters used in this study.</p><p>
<bold>Table&#x000a0;S3</bold>. The DNA sequences of the promoters used in this study.</p><p>
<bold>Table&#x000a0;S4</bold>. Production of edeines A and B calculated from chromatographic peak areas in the fermentation broth of six promoter&#x02010;engineered strains and X23&#x02010;WT.</p><p>
<bold>Table&#x000a0;S5</bold>. Sequences of the primers used in this study.</p><p>
<bold>Fig.&#x000a0;S1</bold>. Plasmid map of pE194&#x02010;edePC&#x02010;Apra&#x02010;Promoter.</p><p>
<bold>Fig.&#x000a0;S2</bold>. Confirmation of appropriate transformant of the promoter&#x02010;engineered <italic toggle="yes">B. brevis</italic> strains by 5&#x02019; and 3&#x02019; junction PCR.</p><p>
<bold>Fig.&#x000a0;S3</bold>. Evaluation of the purity of edeine A based on HPLC and HRMS.</p><p>
<bold>Fig.&#x000a0;S4</bold>. Evaluation of the purity of edeine B based on HPLC and HRMS.</p><p>
<bold>Fig.&#x000a0;S5</bold>. H&#x02010;NMR spectrum of edeine A (600 MHz).</p><p>
<bold>Fig.&#x000a0;S6</bold>. C&#x02010;NMR spectrum of edeine A (150 MHz).</p><p>
<bold>Fig.&#x000a0;S7</bold>. Standard curve of edeines A (a) and B (b).</p><p>
<bold>Fig.&#x000a0;S8</bold>. Construction and functional analyses of the inducible promoters (P<sub>xylA</sub>, P<sub>spc</sub> and P<sub>grac</sub>) with or without repressor protein using the <italic toggle="yes">gfp</italic> reporter gene system in <italic toggle="yes">B. brevis</italic> X23.</p></caption><media xlink:href="MBT2-15-577-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="mbt213825-sec-0017"><title>Acknowledgements</title><p>This work was supported by funding from the National Natural Science Foundation of China (31772216 and 32000047), the National Natural Science Foundation of Hunan Province (2019JJ40169, 2019JJ40119 and 2019JJ40153), the Special Project for Construction of Innovative Province in Hunan (2019NK2192 and 2020NK2006) and the Key Research and Development Project in Changsha (kq2004031). The authors thank Prof. Feng Luo for comments on the manuscript. The authors are also grateful to Prof. Youming Zhang for providing the bacterial strains and Red/ET vectors.</p></ack><ref-list content-type="cited-references" id="mbt213825-bibl-0001"><title>References</title><ref id="mbt213825-bib-0001"><mixed-citation publication-type="journal" id="mbt213825-cit-0001">
<string-name>
<surname>Blin</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Medema</surname>, <given-names>M.H.</given-names>
</string-name>, <string-name>
<surname>Kottmann</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>S.Y.</given-names>
</string-name>, and <string-name>
<surname>Weber</surname>, <given-names>T.</given-names>
</string-name> (<year>2017</year>) <article-title>The antiSMASH database, a comprehensive database of microbial secondary metabolite biosynthetic gene clusters</article-title>. <source>Nucleic Acids Res</source>
<volume>45</volume>: <fpage>D555</fpage>&#x02013;<lpage>D559</lpage>.<pub-id pub-id-type="pmid">27924032</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0002"><mixed-citation publication-type="journal" id="mbt213825-cit-0002">
<string-name>
<surname>Borowska</surname>, <given-names>Z.K.</given-names>
</string-name>, and <string-name>
<surname>Tatum</surname>, <given-names>E.L.</given-names>
</string-name> (<year>1966</year>) <article-title>Biosynthesis of edeine by <italic toggle="yes">Bacillus brevis</italic> Vm4 in&#x000a0;vivo and in&#x000a0;vitro</article-title>. <source>Biochim Biophys Acta</source>
<volume>114</volume>: <fpage>206</fpage>&#x02013;<lpage>209</lpage>.<pub-id pub-id-type="pmid">5936957</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0003"><mixed-citation publication-type="journal" id="mbt213825-cit-0003">
<string-name>
<surname>Chen</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>, <given-names>Q.</given-names>
</string-name>, and <string-name>
<surname>Zhou</surname>, <given-names>Q.</given-names>
</string-name> (<year>2012</year>) <article-title>Draft genome sequence of <italic toggle="yes">Brevibacillus brevis</italic> strain X23, a biocontrol agent against bacterial wilt</article-title>. <source>J Bacteriol</source>
<volume>194</volume>: <fpage>6634</fpage>&#x02013;<lpage>6635</lpage>.<pub-id pub-id-type="pmid">23144389</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0004"><mixed-citation publication-type="journal" id="mbt213825-cit-0004">
<string-name>
<surname>Czajgucki</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Andruszkiewicz</surname>, <given-names>R.</given-names>
</string-name>, and <string-name>
<surname>Kamysz</surname>, <given-names>W.</given-names>
</string-name> (<year>2006</year>) <article-title>Structure activity relationship studies on the antimicrobial activity of novel edeine A and D analogues</article-title>. <source>J Pept Sci</source>
<volume>12</volume>: <fpage>653</fpage>&#x02013;<lpage>662</lpage>.<pub-id pub-id-type="pmid">16847816</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0005"><mixed-citation publication-type="journal" id="mbt213825-cit-0005">
<string-name>
<surname>Czajgucki</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Zimecki</surname>, <given-names>M.</given-names>
</string-name>, and <string-name>
<surname>Andruszkiewicz</surname>, <given-names>R.</given-names>
</string-name> (<year>2007</year>) <article-title>The immunoregulatory effects of edeine analogues in mice</article-title>. <source>Cell Mol Biol Lett</source>
<volume>12</volume>: <fpage>149</fpage>&#x02013;<lpage>161</lpage>.<pub-id pub-id-type="pmid">17149559</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0006"><mixed-citation publication-type="journal" id="mbt213825-cit-0006">
<string-name>
<surname>Czerwinski</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Wojciechowska</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Andruszkiewicz</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Grzybowska</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Gumieniak</surname>, <given-names>J.</given-names>
</string-name>, and <string-name>
<surname>Borowski</surname>, <given-names>E.</given-names>
</string-name> (<year>1983</year>) <article-title>Total synthesis of edeine D</article-title>. <source>J Antibiot (Tokyo)</source>
<volume>36</volume>: <fpage>1001</fpage>&#x02013;<lpage>1006</lpage>.<pub-id pub-id-type="pmid">6415028</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0007"><mixed-citation publication-type="journal" id="mbt213825-cit-0007">
<string-name>
<surname>Ebisu</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Takagi</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Naruse</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Yamagata</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Tsukagoshi</surname>, <given-names>N.</given-names>
</string-name>, and <string-name>
<surname>Udaka</surname>, <given-names>S.</given-names>
</string-name> (<year>1990</year>) <article-title>Conserved structures of cell wall protein genes among protein&#x02010;producing <italic toggle="yes">Bacillus brevis</italic> strains</article-title>. <source>J Bacteriol</source>
<volume>172</volume>: <fpage>1312</fpage>&#x02013;<lpage>1320</lpage>.<pub-id pub-id-type="pmid">2307650</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0008"><mixed-citation publication-type="book" id="mbt213825-cit-0008">
<string-name>
<surname>Green</surname>, <given-names>M.R.</given-names>
</string-name>, and <string-name>
<surname>Sambrook</surname>, <given-names>J.</given-names>
</string-name> (<year>2012</year>) <source>Molecular cloning: a laboratory manual (fourth edition): three&#x02010;volume set</source>. <publisher-loc>New York, NY, USA</publisher-loc>: <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>.</mixed-citation></ref><ref id="mbt213825-bib-0009"><mixed-citation publication-type="journal" id="mbt213825-cit-0009">
<string-name>
<surname>Gui</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Xie</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Mo</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>H.</given-names>
</string-name>, <italic toggle="yes">et&#x000a0;al</italic>. (<year>2019</year>) <article-title>CytA, a reductase in the cytorhodin biosynthesis pathway, inactivates anthracycline drugs in <italic toggle="yes">Streptomyces</italic>
</article-title>. <source>Commun Biol</source>
<volume>2</volume>: <fpage>454</fpage>.<pub-id pub-id-type="pmid">31840099</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0010"><mixed-citation publication-type="journal" id="mbt213825-cit-0010">
<string-name>
<surname>Gumieniak</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Andruszkiewicz</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Czerwi&#x00144;ski</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Grzybowska</surname>, <given-names>J.</given-names>
</string-name>, and <string-name>
<surname>Borowska</surname>, <given-names>Z.</given-names>
</string-name> (<year>1983</year>) <article-title>Synthesis of the decarboxy analog of edeine D</article-title>. <source>J Antibiot (Tokyo)</source>
<volume>36</volume>: <fpage>1239</fpage>&#x02013;<lpage>1241</lpage>.<pub-id pub-id-type="pmid">6415032</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0011"><mixed-citation publication-type="journal" id="mbt213825-cit-0011">
<string-name>
<surname>Hill</surname>, <given-names>S.R.</given-names>
</string-name>, <string-name>
<surname>Bonjouklian</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Powis</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Abraham</surname>, <given-names>R.T.</given-names>
</string-name>, <string-name>
<surname>Ashendel</surname>, <given-names>C.L.</given-names>
</string-name>, and <string-name>
<surname>Zalkow</surname>, <given-names>L.H.</given-names>
</string-name> (<year>1994</year>) <article-title>A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activity</article-title>. <source>Anticancer Drug Des</source>
<volume>9</volume>: <fpage>353</fpage>&#x02013;<lpage>361</lpage>.<pub-id pub-id-type="pmid">7916901</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0012"><mixed-citation publication-type="journal" id="mbt213825-cit-0012">
<string-name>
<surname>Ji</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Baloch</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>M.</given-names>
</string-name>, and <string-name>
<surname>Cao</surname>, <given-names>B.</given-names>
</string-name> (<year>2015</year>) <article-title>Improved production of sublancin via introduction of three characteristic promoters into operon clusters responsible for this novel distinct glycopeptide biosynthesis</article-title>. <source>Microb Cell Fact</source>
<volume>14</volume>: <fpage>17</fpage>.<pub-id pub-id-type="pmid">25879813</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0013"><mixed-citation publication-type="journal" id="mbt213825-cit-0013">
<string-name>
<surname>Johnson</surname>, <given-names>E.T.</given-names>
</string-name>, <string-name>
<surname>Bowman</surname>, <given-names>M.J.</given-names>
</string-name>, and <string-name>
<surname>Dunlap</surname>, <given-names>C.A.</given-names>
</string-name> (<year>2020</year>) <article-title>
<italic toggle="yes">Brevibacillus</italic> fortis NRS&#x02010;1210 produces edeines that inhibit the in&#x000a0;vitro growth of conidia and chlamydospores of the onion pathogen <italic toggle="yes">Fusarium oxysporum</italic> f. sp. cepae</article-title>. <source>Antonie Van Leeuwenhoek</source>
<volume>113</volume>: <fpage>973</fpage>&#x02013;<lpage>987</lpage>.<pub-id pub-id-type="pmid">32279200</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0014"><mixed-citation publication-type="journal" id="mbt213825-cit-0014">
<string-name>
<surname>Jung</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Yu</surname>, <given-names>K.O.</given-names>
</string-name>, <string-name>
<surname>Ramzi</surname>, <given-names>A.B.</given-names>
</string-name>, <string-name>
<surname>Choe</surname>, <given-names>S.H.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>S.W.</given-names>
</string-name>, and <string-name>
<surname>Han</surname>, <given-names>S.O.</given-names>
</string-name> (<year>2012</year>) <article-title>Improvement of surfactin production in <italic toggle="yes">Bacillus subtilis</italic> using synthetic wastewater by overexpression of specific extracellular signaling peptides, <italic toggle="yes">comX</italic> and <italic toggle="yes">phrC</italic>
</article-title>. <source>Biotechnol Bioeng</source>
<volume>109</volume>: <fpage>2349</fpage>&#x02013;<lpage>2356</lpage>.<pub-id pub-id-type="pmid">22511326</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0015"><mixed-citation publication-type="journal" id="mbt213825-cit-0015">
<string-name>
<surname>Keeney</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Ruzin</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>McAleese</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>, <given-names>E.</given-names>
</string-name>, and <string-name>
<surname>Bradford</surname>, <given-names>P.A.</given-names>
</string-name> (<year>2008</year>) <article-title>MarA&#x02010;mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in <italic toggle="yes">Escherichia coli</italic>
</article-title>. <source>J Antimicrob Chemother</source>
<volume>61</volume>: <fpage>46</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">17967850</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0016"><mixed-citation publication-type="journal" id="mbt213825-cit-0016">
<string-name>
<surname>Kiero&#x00144;ska</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>R&#x000f3;zalska</surname>, <given-names>B.</given-names>
</string-name>, and <string-name>
<surname>Zablocki</surname>, <given-names>B.</given-names>
</string-name> (<year>1976</year>) <article-title>Immunosuppressive properties of the antibiotic edeine</article-title>. <source>Bull Acad Pol Sci Biol</source>
<volume>24</volume>: <fpage>705</fpage>&#x02013;<lpage>710</lpage>.<pub-id pub-id-type="pmid">797433</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0017"><mixed-citation publication-type="journal" id="mbt213825-cit-0017">
<string-name>
<surname>Kim</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Mogk</surname>, <given-names>A.</given-names>
</string-name>, and <string-name>
<surname>Schumann</surname>, <given-names>W.</given-names>
</string-name> (<year>1996</year>) <article-title>A xylose&#x02010;inducible <italic toggle="yes">Bacillus subtilis</italic> integration vector and its application</article-title>. <source>Gene</source>
<volume>181</volume>: <fpage>71</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">8973310</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0018"><mixed-citation publication-type="journal" id="mbt213825-cit-0018">
<string-name>
<surname>Kunga Sugumaran</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Gopinath</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Palani</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Arumugam</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Jose</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bahadur</surname>, <given-names>A.</given-names>
</string-name>, and <string-name>
<surname>Ilangovan</surname>, <given-names>R.</given-names>
</string-name> (<year>2016</year>) <article-title>Plant pathogenic fungus <italic toggle="yes">F. solani</italic> mediated biosynthesis of nanoceria: antibacterial and antibiofilm activity</article-title>. <source>RSC Adv</source>
<volume>6</volume>: <fpage>42720</fpage>&#x02013;<lpage>42729</lpage>.</mixed-citation></ref><ref id="mbt213825-bib-0019"><mixed-citation publication-type="journal" id="mbt213825-cit-0019">
<string-name>
<surname>Kurylo&#x02010;Borowska</surname>, <given-names>Z.</given-names>
</string-name>, and <string-name>
<surname>Szer</surname>, <given-names>W.</given-names>
</string-name> (<year>1972</year>) <article-title>Inhibition of bacterial DNA synthesis by edeine. Effect on <italic toggle="yes">Escherichia coli</italic> mutants lacking DNA polymerase I</article-title>. <source>Biochim Biophys Acta</source>
<volume>287</volume>: <fpage>236</fpage>&#x02013;<lpage>245</lpage>.<pub-id pub-id-type="pmid">4609469</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0020"><mixed-citation publication-type="journal" id="mbt213825-cit-0020">
<string-name>
<surname>Liu</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Shen</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Bian</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Fu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>H.</given-names>
</string-name>, <italic toggle="yes">et&#x000a0;al</italic>. (<year>2016</year>) <article-title>Simple and rapid direct cloning and heterologous expression of natural product biosynthetic gene cluster in <italic toggle="yes">Bacillus subtilis</italic> via Red/ET recombineering</article-title>. <source>Sci Rep</source>
<volume>6</volume>: <elocation-id>34623</elocation-id>.<pub-id pub-id-type="pmid">27687863</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0021"><mixed-citation publication-type="book" id="mbt213825-cit-0021">
<string-name>
<surname>Lu</surname>, <given-names>X.</given-names>
</string-name> (<year>2014</year>) <source>The purification and identification of the antimicrobial peptide edeine B secreted by <italic toggle="yes">Brevibacillus brevis</italic> X23</source>. Master Dissertation of Hunan Agricultural University, China.</mixed-citation></ref><ref id="mbt213825-bib-0022"><mixed-citation publication-type="journal" id="mbt213825-cit-0022">
<string-name>
<surname>Marahiel</surname>, <given-names>M.A.</given-names>
</string-name>, <string-name>
<surname>Zuber</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Czekay</surname>, <given-names>G.</given-names>
</string-name>, and <string-name>
<surname>Losick</surname>, <given-names>R.</given-names>
</string-name> (<year>1987</year>) <article-title>Identification of the promoter for a peptide antibiotic biosynthesis gene from <italic toggle="yes">Bacillus brevis</italic> and its regulation in <italic toggle="yes">Bacillus subtilis</italic>
</article-title>. <source>J Bacteriol</source>
<volume>169</volume>: <fpage>2215</fpage>&#x02013;<lpage>2222</lpage>.<pub-id pub-id-type="pmid">3032912</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0023"><mixed-citation publication-type="journal" id="mbt213825-cit-0023">
<string-name>
<surname>Mazerski</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wojciechowska</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Zgoda</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Woynarowska</surname>, <given-names>B.</given-names>
</string-name>, and <string-name>
<surname>Borowska</surname>, <given-names>Z.</given-names>
</string-name> (<year>1981</year>) <article-title>Esters and amides of edeine A</article-title>. <source>J Antibiot (Tokyo)</source>
<volume>34</volume>: <fpage>28</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">7251506</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0024"><mixed-citation publication-type="journal" id="mbt213825-cit-0024">
<string-name>
<surname>Mizukami</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Hanagata</surname>, <given-names>H.</given-names>
</string-name>, and <string-name>
<surname>Miyauchi</surname>, <given-names>A.</given-names>
</string-name> (<year>2010</year>) <article-title>
<italic toggle="yes">Brevibacillus</italic> expression system: host&#x02010;vector system for efficient production of secretory proteins</article-title>. <source>Curr Pharm Biotechnol</source>
<volume>11</volume>: <fpage>251</fpage>&#x02013;<lpage>258</lpage>.<pub-id pub-id-type="pmid">20210747</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0025"><mixed-citation publication-type="journal" id="mbt213825-cit-0025">
<string-name>
<surname>Muyrers</surname>, <given-names>J.P.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>Y.</given-names>
</string-name>, and <string-name>
<surname>Stewart</surname>, <given-names>A.F.</given-names>
</string-name> (<year>2001</year>) <article-title>Techniques: recombinogenic engineering&#x02010;new options for cloning and manipulating DNA</article-title>. <source>Trends Biochem Sci</source>
<volume>26</volume>: <fpage>325</fpage>&#x02013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">11343926</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0026"><mixed-citation publication-type="journal" id="mbt213825-cit-0026">
<string-name>
<surname>Navarro&#x02010;Mu&#x000f1;oz</surname>, <given-names>J.C.</given-names>
</string-name>, <string-name>
<surname>Selem&#x02010;Mojica</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Mullowney</surname>, <given-names>M.W.</given-names>
</string-name>, <string-name>
<surname>Kautsar</surname>, <given-names>S.A.</given-names>
</string-name>, <string-name>
<surname>Tryon</surname>, <given-names>J.H.</given-names>
</string-name>, <string-name>
<surname>Parkinson</surname>, <given-names>E.I.</given-names>
</string-name>, <italic toggle="yes">et&#x000a0;al</italic>. (<year>2020</year>) <article-title>A computational framework to explore large&#x02010;scale biosynthetic diversity</article-title>. <source>Nat Chem Biol</source>
<volume>16</volume>: <fpage>60</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">31768033</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0027"><mixed-citation publication-type="journal" id="mbt213825-cit-0027">
<string-name>
<surname>Okamoto</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Kosugi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Koizumi</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Yanagida</surname>, <given-names>F.</given-names>
</string-name>, and <string-name>
<surname>Udaka</surname>, <given-names>S.</given-names>
</string-name> (<year>1997</year>) <article-title>High efficiency transformation of <italic toggle="yes">Bacillus brevis</italic> by electroporation</article-title>. <source>Biosci Biotechnol Biochem</source>
<volume>61</volume>: <fpage>202</fpage>&#x02013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">9028054</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0028"><mixed-citation publication-type="journal" id="mbt213825-cit-0028">
<string-name>
<surname>Phan</surname>, <given-names>T.T.</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>, <given-names>H.D.</given-names>
</string-name>, and <string-name>
<surname>Schumann</surname>, <given-names>W.</given-names>
</string-name> (<year>2006</year>) <article-title>Novel plasmid&#x02010;based expression vectors for intra&#x02010; and extracellular production of recombinant proteins in <italic toggle="yes">Bacillus subtilis</italic>
</article-title>. <source>Protein Expr Purif</source>
<volume>46</volume>: <fpage>189</fpage>&#x02013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">16125412</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0029"><mixed-citation publication-type="journal" id="mbt213825-cit-0029">
<string-name>
<surname>Pioletti</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Schlunzen</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Harms</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Zarivach</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Gluhmann</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Avila</surname>, <given-names>H.</given-names>
</string-name>, and <string-name>
<surname>Franceschi</surname>, <given-names>F.</given-names>
</string-name> (<year>2001</year>) <article-title>Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3</article-title>. <source>EMBO J</source>
<volume>20</volume>: <fpage>1829</fpage>&#x02013;<lpage>1839</lpage>.<pub-id pub-id-type="pmid">11296217</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0030"><mixed-citation publication-type="journal" id="mbt213825-cit-0030">
<string-name>
<surname>Polikanov</surname>, <given-names>Y.S.</given-names>
</string-name>, <string-name>
<surname>Aleksashin</surname>, <given-names>N.A.</given-names>
</string-name>, <string-name>
<surname>Beckert</surname>, <given-names>B.</given-names>
</string-name>, and <string-name>
<surname>Wilson</surname>, <given-names>D.N.</given-names>
</string-name> (<year>2018</year>) <article-title>The mechanisms of action of ribosome&#x02010;targeting peptide antibiotics</article-title>. <source>Front Mol Biosci</source>
<volume>5</volume>: <fpage>48</fpage>.<pub-id pub-id-type="pmid">29868608</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0031"><mixed-citation publication-type="journal" id="mbt213825-cit-0031">
<string-name>
<surname>Sharan</surname>, <given-names>S.K.</given-names>
</string-name>, <string-name>
<surname>Thomason</surname>, <given-names>L.C.</given-names>
</string-name>, <string-name>
<surname>Kuznetsov</surname>, <given-names>S.G.</given-names>
</string-name>, and <string-name>
<surname>Court</surname>, <given-names>D.L.</given-names>
</string-name> (<year>2009</year>) <article-title>Recombineering: a homologous recombination&#x02010;based method of genetic engineering</article-title>. <source>Nat Protoc</source>
<volume>4</volume>: <fpage>206</fpage>&#x02013;<lpage>223</lpage>.<pub-id pub-id-type="pmid">19180090</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0032"><mixed-citation publication-type="journal" id="mbt213825-cit-0032">
<string-name>
<surname>Shimotohno</surname>, <given-names>K.W.</given-names>
</string-name>, <string-name>
<surname>Iida</surname>, <given-names>J.</given-names>
</string-name>, and <string-name>
<surname>Endo</surname>, <given-names>T.</given-names>
</string-name> (<year>1999</year>) <article-title>A new enzyme, edeine B1 amidinohydrolase, from <italic toggle="yes">Bacillus brevis</italic> TT02&#x02010;8. Purification and determination of the N&#x02010;terminal amino acid sequence</article-title>. <source>J Antibiot (Tokyo)</source>
<volume>52</volume>: <fpage>407</fpage>&#x02013;<lpage>411</lpage>.<pub-id pub-id-type="pmid">10395276</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0033"><mixed-citation publication-type="journal" id="mbt213825-cit-0033">
<string-name>
<surname>Sun</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Bie</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Lu</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Lu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>, <given-names>Y.</given-names>
</string-name>, and <string-name>
<surname>Lu</surname>, <given-names>Z.</given-names>
</string-name> (<year>2009</year>) <article-title>Enhancement of surfactin production of <italic toggle="yes">Bacillus subtilis</italic> fmbR by replacement of the native promoter with the Pspac promoter</article-title>. <source>Can J Microbiol</source>
<volume>55</volume>: <fpage>1003</fpage>&#x02013;<lpage>1006</lpage>.<pub-id pub-id-type="pmid">19898540</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0034"><mixed-citation publication-type="journal" id="mbt213825-cit-0034">
<string-name>
<surname>Szaflarski</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Vesper</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Teraoka</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Plitta</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>, <given-names>D.N.</given-names>
</string-name>, and <string-name>
<surname>Nierhaus</surname>, <given-names>K.H.</given-names>
</string-name> (<year>2008</year>) <article-title>New features of the ribosome and ribosomal inhibitors: non&#x02010;enzymatic recycling, misreading and back&#x02010;translocation</article-title>. <source>J Mol Biol</source>
<volume>380</volume>: <fpage>193</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="pmid">18508080</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0035"><mixed-citation publication-type="journal" id="mbt213825-cit-0035">
<string-name>
<surname>Takahashi</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Yamagata</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Yamaguchi</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Tsukagoshi</surname>, <given-names>N.</given-names>
</string-name>, and <string-name>
<surname>Udaka</surname>, <given-names>S.</given-names>
</string-name> (<year>1983</year>) <article-title>Genetic transformation of <italic toggle="yes">Bacillus brevis</italic> 47, a protein&#x02010;secreting bacterium, by plasmid DNA</article-title>. <source>J Bacteriol</source>
<volume>156</volume>: <fpage>1130</fpage>&#x02013;<lpage>1134</lpage>.<pub-id pub-id-type="pmid">6358189</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0036"><mixed-citation publication-type="journal" id="mbt213825-cit-0036">
<string-name>
<surname>Tran</surname>, <given-names>D.T.M.</given-names>
</string-name>, <string-name>
<surname>Phan</surname>, <given-names>T.T.P.</given-names>
</string-name>, <string-name>
<surname>Huynh</surname>, <given-names>T.K.</given-names>
</string-name>, <string-name>
<surname>Dang</surname>, <given-names>N.T.K.</given-names>
</string-name>, <string-name>
<surname>Huynh</surname>, <given-names>P.T.K.</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>, <given-names>T.M.</given-names>
</string-name>, <italic toggle="yes">et&#x000a0;al</italic>. (<year>2017</year>) <article-title>Development of inducer&#x02010;free expression plasmids based on IPTG&#x02010;inducible promoters for <italic toggle="yes">Bacillus subtilis</italic>
</article-title>. <source>Microb Cell Fact</source>
<volume>16</volume>: <fpage>130</fpage>.<pub-id pub-id-type="pmid">28743271</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0037"><mixed-citation publication-type="journal" id="mbt213825-cit-0037">
<string-name>
<surname>Westman</surname>, <given-names>E.L.</given-names>
</string-name>, <string-name>
<surname>Yan</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Waglechner</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Koteva</surname>, <given-names>K.</given-names>
</string-name>, and <string-name>
<surname>Wright</surname>, <given-names>G.D.</given-names>
</string-name> (<year>2013</year>) <article-title>Self resistance to the atypical cationic antimicrobial peptide edeine of <italic toggle="yes">Brevibacillus brevis</italic> Vm4 by the N&#x02010;acetyltransferase EdeQ</article-title>. <source>Chem Biol</source>
<volume>20</volume>: <fpage>983</fpage>&#x02013;<lpage>990</lpage>.<pub-id pub-id-type="pmid">23891151</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0038"><mixed-citation publication-type="journal" id="mbt213825-cit-0038">
<string-name>
<surname>Yan</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Yu</surname>, <given-names>H.J.</given-names>
</string-name>, <string-name>
<surname>Hong</surname>, <given-names>Q.</given-names>
</string-name>, and <string-name>
<surname>Li</surname>, <given-names>S.P.</given-names>
</string-name> (<year>2008</year>) <article-title>Cre/lox system and PCR&#x02010;based genome engineering in <italic toggle="yes">Bacillus subtilis</italic>
</article-title>. <source>Appl Environ Microbiol</source>
<volume>74</volume>: <fpage>5556</fpage>&#x02013;<lpage>5562</lpage>.<pub-id pub-id-type="pmid">18641148</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0039"><mixed-citation publication-type="journal" id="mbt213825-cit-0039">
<string-name>
<surname>Yang</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Ji</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Cao</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>Y.</given-names>
</string-name>, and <string-name>
<surname>Zhao</surname>, <given-names>X.</given-names>
</string-name> (<year>2013</year>) <article-title>Generation of an artificial double promoter for protein expression in <italic toggle="yes">Bacillus subtilis</italic> through a promoter trap system</article-title>. <source>PLoS One</source>
<volume>8</volume>: <elocation-id>e56321</elocation-id>.<pub-id pub-id-type="pmid">23409173</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0040"><mixed-citation publication-type="journal" id="mbt213825-cit-0040">
<string-name>
<surname>Yansura</surname>, <given-names>D.G.</given-names>
</string-name>, and <string-name>
<surname>Henner</surname>, <given-names>D.J.</given-names>
</string-name> (<year>1984</year>) <article-title>Use of the <italic toggle="yes">Escherichia coli</italic> lac repressor and operator to control gene expression in <italic toggle="yes">Bacillus subtilis</italic>
</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>81</volume>: <fpage>439</fpage>&#x02013;<lpage>443</lpage>.<pub-id pub-id-type="pmid">6420789</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0041"><mixed-citation publication-type="journal" id="mbt213825-cit-0041">
<string-name>
<surname>Ye</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>J.H.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>B.G.</given-names>
</string-name>, <string-name>
<surname>Szarka</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Sihota</surname>, <given-names>E.</given-names>
</string-name>, and <string-name>
<surname>Wong</surname>, <given-names>S.L.</given-names>
</string-name> (<year>1999</year>) <article-title>High&#x02010;level secretory production of intact, biologically active staphylokinase from <italic toggle="yes">Bacillus subtilis</italic>
</article-title>. <source>Biotechnol Bioeng</source>
<volume>62</volume>: <fpage>87</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">10099516</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0042"><mixed-citation publication-type="journal" id="mbt213825-cit-0042">
<string-name>
<surname>Yu</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Ellis</surname>, <given-names>H.M.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>E.C.</given-names>
</string-name>, <string-name>
<surname>Jenkins</surname>, <given-names>N.A.</given-names>
</string-name>, <string-name>
<surname>Copeland</surname>, <given-names>N.G.</given-names>
</string-name>, and <string-name>
<surname>Court</surname>, <given-names>D.L.</given-names>
</string-name> (<year>2000</year>) <article-title>An efficient recombination system for chromosome engineering in <italic toggle="yes">Escherichia coli</italic>
</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>97</volume>: <fpage>5978</fpage>&#x02013;<lpage>5983</lpage>.<pub-id pub-id-type="pmid">10811905</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0043"><mixed-citation publication-type="journal" id="mbt213825-cit-0043">
<string-name>
<surname>Zhang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Feng</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Du</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Tian</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, and <string-name>
<surname>Zhang</surname>, <given-names>X.H.</given-names>
</string-name> (<year>2019</year>) <article-title>Heterologous expression of the marine&#x02010;derived quorum quenching enzyme MomL can expand the antibacterial spectrum of <italic toggle="yes">Bacillus brevis</italic>
</article-title>. <source>Mar Drugs</source>
<volume>17</volume>: <fpage>128</fpage>.</mixed-citation></ref><ref id="mbt213825-bib-0044"><mixed-citation publication-type="journal" id="mbt213825-cit-0044">
<string-name>
<surname>Zhang</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>L&#x000fc;</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Duan</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Huang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Du</surname>, <given-names>J.</given-names>
</string-name>, and <string-name>
<surname>Chen</surname>, <given-names>W.</given-names>
</string-name> (<year>2020</year>) <article-title>Effect of transcription factor AbrB on the biosynthesis of antibiotic edeines in biocontrol bacteria <italic toggle="yes">Brevibacillus brevis</italic> X23</article-title>. <source>Chinese Journal of Biological Control</source>
<volume>36</volume>: <fpage>564</fpage>&#x02013;<lpage>574</lpage>.</mixed-citation></ref><ref id="mbt213825-bib-0045"><mixed-citation publication-type="journal" id="mbt213825-cit-0045">
<string-name>
<surname>Zhang</surname>, <given-names>M.M.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Ang</surname>, <given-names>E.L.</given-names>
</string-name>, and <string-name>
<surname>Zhao</surname>, <given-names>H.</given-names>
</string-name> (<year>2016</year>) <article-title>Engineering microbial hosts for production of bacterial natural products</article-title>. <source>Nat Prod Rep</source>
<volume>33</volume>: <fpage>963</fpage>&#x02013;<lpage>987</lpage>.<pub-id pub-id-type="pmid">27072804</pub-id></mixed-citation></ref><ref id="mbt213825-bib-0046"><mixed-citation publication-type="journal" id="mbt213825-cit-0046">
<string-name>
<surname>Zhang</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Muyrers</surname>, <given-names>J.P.</given-names>
</string-name>, <string-name>
<surname>Testa</surname>, <given-names>G.</given-names>
</string-name>, and <string-name>
<surname>Stewart</surname>, <given-names>A.F.</given-names>
</string-name> (<year>2000</year>) <article-title>DNA cloning by homologous recombination in <italic toggle="yes">Escherichia coli</italic>
</article-title>. <source>Nat Biotechnol</source>
<volume>18</volume>: <fpage>1314</fpage>&#x02013;<lpage>1317</lpage>.<pub-id pub-id-type="pmid">11101815</pub-id></mixed-citation></ref></ref-list></back></article>